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4S U M M A R Y
A method for fractionation of HCG in hydatidiform
mole has been devised and is proved to be efficient and
simple. Four steps are required:
1. Salt precipitation;
2. Sephadex G-200 chromatography;
3. DEAE Sephadex A-50 chromatography; and
4. Sephadex G-100 chromatography.
The yield of the final product amounts to as high
as 0.27 percent on dry wreight basis and to 19.7 percent
on the basis of HCG activity.
The final product so obtained is homogeneous with
only one band present as exhibited by polyacrylamide and
starch gel electrophoresis. N-terminal analysis shows
the presence of alanine and serine, due to alpha and beta
subunits of HCG. The elution pattern of the final product
in Sephadex G-100 displays a symmetrical profile. These
findings indicate homogeneity of the final product.
Molar HCG is found to have a molecular weight of
6.3 x 104, which is slightly higher than urinary HCG,
(3.7 x 104- 5.9 x 104). Its pi is 4.2.
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I N T R O D U C T I 0 N
Hydatidiform molc is essentially placental disorder
which continues to function aftci;r the embryo has died and
disappeared. The chorionic villi degenerate and become
enlarged into fluid-filled., colourless, grape-like clusters.
In Chinese it:. is called grape-pregnancy
Hydati.difor. m mole is characterized by the abnormally
high level of excretion of human chorionic gonadotrophins
(HCG) in blood and in urine. If the molar tissue are not
removed from uterine cavity, it will change into chorio-
epithelioma, also known as choriocarcinoma, a malignant
tumor. It is very rapidly spread. to the lung (Fig. 2),
Hydatidi.formn mole is rare in Europe but relatively
common in the Far East. In Hong Kong the incidence is
1:242 diliveries as compared with 1:2,000 deliveries in
European countries (1). Some enzymatic s tudie3 of molar
tissue had been investigated and compared with the normal
placenta. It was found that the ratio of d/B lipoprotein
in serum, as estimated by paper electrophoresis, of hyda-
tidiform mole was significantly lower than that in normal
pregnancy (2). The activity of both acid and alkaline
phosphatases in the by datidiform mole tissue was found to
be much lower than that in the normal placenta (3) while
the activity of the lactate dehydrogenase in molar tissue
( 葡 萄 胎 ) (Fig. 1).
2was higher (4). The isoenzyme pattern of lactate deh.ydro-
genase (4); acid and alkaline phosphatase (5) of molar
tissue in starch gel electrophoresis differed from that
of- normal placenta. All these results of enzymatic studies
revealed there were qualitative as well as quantitative
differences between. molar tissue and normal placenta.
Since hydatidiforn mole produces large amount of gonado-
trophins and inadequate or excessive production of hormone
will seriously disturb the physiological role of the organ
thereby resulting in organ disorder. Recently, urinary
gonadotrophins had been detected in carcinoma of the lung,
.stomach and esophagus (6). All these findings lect us to
consider that there may be some relationship between this
abnormality of HCG secretion and the factors which cons-
titute the causes of hydatidiform mole,
HCG is a glycoprotein produced by the placenta. It
was first found by Aschheim and Zondek in 1927 (7). Since
then, the property of HCG has been used as the indication
of pregnancy. Urinary HCC has been isolated by Bahl (8)
and other workers (9, 10, 11, 12, 13, 14) and its sequence
of amino acid has recently been reported (15). Although
the urinary HCC had been extensively studied, very few
workers' deal with this hormone from the tissue. However,
the HCG present in hydatidiforni mole has not been successfully
purified (16).
3Fig. 1. The grape-like molar tissue after the'
uterus was opened.
Fig. 2. The specimen of cho.rioep:itheiionla.
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Because of its high ineidence in the Far East and
fresh specimens can be obtained conveniontly in Hong Kong,
chemical studies of this gonadotrophin in hydatidiform
mole is signifieant. In order to study the structure and
the properties of this protein hormone, it is essential
to prepare a pure, clean product which is homogeneous as
ascertained by physical and chemical methods as well as
by bionassay.
In this study, we had investigated methods to purify
HCG from the molar tissue. We were able to fractionate
the molar HCG in pure form with good yield.
5L I T E R A T U R E R E V I E W
PART A. HYDATIDIFORM MOLE
Definition wand Classification (17, 18, 19, 20)
Hydatidiform mole may be defined as a tumor composed
of cystically dilated chorion-i.ic villi (Hydatid, in Latin,
means a drop of water of any cyst-like structure; and mole,
a mass.). It can always be regarded as a potentially mmmali-
gnant condition but the activity of the chorion is extremely
variable. I-soles can be classified into groups, the distin-
guishing features being clinical behaviour rather than
histological appearance,
a. Hydatidiform mole---- The chorionic overactivity is
indicated by a tendency to invade the uterine wall
more deeply than usual and when mole is removed,
small fragments tend to remain in the myometrium,
b. Malignant mole; invasive mole; chorio-adenoma
destruens-- These are synonymous terms for a mole
which behaves like a locally malignant growth,
invading so deeply that it may perforate the uterine
wall and involve adjacent organs.
c. Metastasizing mole-- The moles give rise to blood-
borne deposits which are found most often in the
lungs and vagina. This is similar to that of
chorioca1 cinommma.
6II. History
Molar pregnancy was first recorded in thirteenth
century in Europe (21). On Good Friday of the year 1276
in the village of Loosduinen near the Hague, Margaret,
Countess of Henneberg, went into labor and was delivered
of a product of pregnancy which caused the greatest cons.-
ternation. This case was recorded on a large wooden
tablet still hanging on the side wall of the village
church, flanked by two big brass basins in which the "boys
and girls" were baptized. On the tablet, it says: "Margaret,
wife of Herman, Earl of Henneberg, Daughter of Floris IV,
Earl of Holland and Sealand,........ this highborn Countess,
about 42 years of age, was on Good Friday of the year 1927
at about 9 O'clock brought to bed of 365 children who, all
together were baptized in two basins by Guido, Suffragan
of Utrecht; the boys were all christened John, the girls
Elizabeth; who all, together with the mother, died on the
same day and were buried here at Loosduinen in the church;
which has happened because of a poor woman, who carried
two children of one gestation on her arms, of which the
countess, being amazed, declared that she could not have
them by one man, and shook her off with comtenipt; where-
upon this poor woman, being annoyed, cursed her with the
wish that of one gestation as many children she might have
7as there were days in a wholc year, which miraculously
came to pass, as here, for mnetmmory' s saake, is briefly
copied and narrated from hand-written as well as printed
old chronicles on this tablet."
Several Dutch physicians of the seventeenth century
reported the occurrence of moles (21). The physician
Nicolaas Tuip discribed two cases of mole in his "Obser-
vations Medicase" in 1641 (21). It is remarkable that
both women had afterward normal pregnancies. Reimer de,
Graaf, the first to describe the follicle in the ovary named
after him, held this follicle responsible for the origin
of the mole. Toward the end of the seventeenth century
the Amsterdam physician Frederik Ruysch gave some beautiful
illustration of a total as well as of a partial mole (21).
In France, Madame Boivin (1827) dedicated a charming booklet
to her views on the vesicular mole (39). Velpean (1827)
was the first to see molar vesicle as result of hydropic
degeneration of chorionic villi (4o). Since nineteenth
century, knowledge about hydatidiform mole such as the
etiology, pathology, incidence and therapy of molar patients
had been accumulated and studied. This placental. disorder
is still an active field of study in obstetrics and. gynecol ogy
and much remains to be investigated in order to obtain a
better picture of molar pregnancy. It should be emphasized
8
that an approach from the molecular basis of HCG will be
usefu, if not essential, in, understanding this disorder
III. Incidence
Hydatid:i for in mole is not uncommon. The incidence
varies with geographical regions. Generally speaking,
it is between one in 125-21000 deliveries (22). It is
extraordinary that moles are common in certain Far East
and African countries but rare in Europe and America.
Fig. 3 shows the geographic incidence of hydatidiform
mole. It occurs during the childbearing age of women,
usually from the age of 25 to 45.. One-third of all cases
occur in women more than 40 years of age. Most of the
cases were developed from retained placental tissue follow-
ing delivery or more often following abortion. The interval
elapsing between the gestation and the appearance of the
tumor is usually only a few weeks or months, but occasionally
it is several. years.
Chun et al. (l) reported that the incidence in Hong
Kong is one in 242 deliveries.
IV. Site and Gross Appearance
Since hydatidif orm mole, is a placental disorder,it























may develop wherever the placenta becomes implantcd,
usually occurs in the uterir .e c c :Lt y which compri e s 90
of cases, but it may also occur in, ectopic sites.
In molar pregnancy, the uterus is usually enlarged
to that of a three- or four-month gestation. The inyornetriuin
is thickened, relatively vascular, and somewhat edematous
The endornetriurn is pink, soft and abundant, being equivalent
to that found in the secretory phase of the menstrual cycle,
The uterine cavity *is enlarged and filled with grape-like
molar tissue. The placenta may be affected in part of in
whole. It is composed of numerous, thin-walled, cystic
structure varying in sizes from a feiv- millimeters to two
or three centimeters in diameter (Fig. 4). They are gray,
transparent and collapsible. The cystic fluid is usually
clear, watery of straw-coloured. The cysts are generally
joined with each other and to the underlying chorionic
plate by narrow pedicles of connective tissue.
V Patholo
Three pathologic changes which characterize hydatitl-
diform mole are
a. trophobla stic proliferation;
b. hydropic degeneration of the villous stroma;
c. scantiness of blood vessels.
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Fig. 4. The molar tissue is composed of numerous
thin-walled, cystic structure varying in
sizes from a few millimeters to two or
three centimeters in diameter.
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The mole can be regarded as a neoplasm of the chorion
which affects Langhan's cells and syncytium, in different
proportions in different cases. Although the histological
picture varies, the typical mole shows irregular prolife-
ration and pleomorphism of epithelial cells whose nuclei
are hyperchromatic and actively mitotic (Fig.5). The
stroma of each villus is at first edematous, but soon the
whole central core, including most of the vessels is des-
troyed. The villus then swells to form a round cyst filled
with watery fluid. The chorion thus becomes converted into
a mass of grape-like structures each attached by a fine
stalk (Fig.6). The cysts vary in sizes from a pin head
to a cherry.
Usually, early death of the fetus results and the mole
is expelled, but parts of the hydatidiform placental tissue,
which tends to burrow into the uterine wall (invasive mole)
are often left behind and these may become chorion-epithe-
liomatous, also known as chorio-carcinoma(Fig.7). About
50% of chorion-epitheliomas are preceded by recognized
hydatidiform moles and the risk is highest when the patient
is over 40 years of age.
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Fig. 5. The section of molar tissue showing the
nuclei are hyperchrormatic.
Fig. 6. The molar tissue. The left side is the
uterine wall. The grape-like cystic
structure are attached by fine stalks.
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Fig. 7. The specimen of chorioepithelionla. The
ovaries on both side of the uterus are
also affected.
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VI. Theory of Causation of Hydatidiform Mold
The causes of hydatidiform degeneration of the
placenta are unknown; there are good reasons for believing
them to depend on defective development of embryo itself
rather than on nutritional abnormalities of the mother.
Ordinary embryo becomes degenerated, absorbed, or other-
wise distorted to the point where it can no longer be
recognized. Some authorities (21) believed that hydati-
dif.orm change follows rather than. precedes fetal death.
The theories of causation are:
a. Death of the fetus result in failure of the
circulation in the villi and therefore in oedema
and liquefaction of the stroma;
b. A primary error in the development of the fetal
vessels causes the villi to become overloaded
with fluid and food stuffs
In 1940, Hertig and Edmonds (41) demonstrated that
the key to the development of a typical hyd.a ti diform mole
was some deformity of the ovum or early death of the fetus,
In a typical case the embryo ceases developing during the
third and fourth weeks of its growth (5th-6th weeks of
pregnancy). It is at this stage that the vessels of the
villi begin to form continuous channels, the fetal vascula.r
system begins to function, the trophoblast is active, and
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the villi are large and edematons. when the embryo diea
or is absent the chorion keeps on growing before abortion
occurs, but the vessels of the vi11 do not develop for
they have no function to perform. Also, for the same
reason, the primitive vessels or anlagen that have deve-
loped regress and disappear. Since the trophoblast remains
active, however, the villi continue to function normally
but because of lack of blood vessels, their inhibition or
secretion products accumulate resulting in. edema and cystic
change.
VII. HCG Output in Urine
Hydatidiform moles secrete abnormally large amounts
of gonadotrophins due to the overactivity of the chorion.
These appear in the urine and also act on the patient's
own ovaries to produce excessive luteinization which may
take the form of Multiple theca lutein cysts. The abnor-
mally large amlourrts of gonadotrophins give a strongly
positive Aschhiem-Zondek or pregnancy test. The amount
of HCG secreted from a normal placenta in the first
trimester of pregnancy is approximately 30,000-50,000
International Unit (IU) per day, while in the patients
of hydatidiform mole, a 100-fold increase of IICG secretion,
i.e. 3,000,000-5,000,000 I.U. is commonly fotu.xnd.
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PART B. PURIFICATION OF HUMAN CHORIONIC CONADOTNOFUIN
Since the discovery of HCG by Aschheim and Zoadek
in 1927 (7), many workers began interested in studying
this hormone. Before any physicochemical studies can be
made to ascertain its properties, it is essential to
obtain this hormone in a highly active and pure form.
During the last decade, biochemsts had made great effort
to purify this gonadotrophin hormone from the urine of
pregnant women. Much work had been done, yet diverse
results were reported. The principle handicap in the
purification is due to the "micro-heterogeneity''of HCG
molecule probably because of the instability of the
carbohydrate moiety of the molecule. How- 7ever, many
chemical properties of the urinary HCG molecule are known
and its amino acid sequence has recently reported (15).
Between 1928 and 1954, a number of methods were
described to extract urinary HCG. The notable ones are
men boned below- because of their historical importance.
a. Ethanol precipitation method by Zondek and Aschheim
in 1928 (25).
b. Acetone precipitation method by Frank and Salmon
in 1935 (26).
C. Benzoic- tungstic acid absorption by Katzman
et al., in 1943 (27).
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d. Kaolin adsorption with or without acetonc
precipitation. by Scott in 1941 (28), Loraine in
1950 and 1951 (29,3O)
These methods could only purify the protein in a
crude stater The following is a review of the fractiona-
tion methods in details.
I. Method of Got and Bourrillon (1960)
The purification of HCG with relatively high bio-
logical activity and purity began in 1960. Got and
Bourrillon (9) deviced a method of purifying urinary
HCG from pregnant women. The hormone was first adsorped
with benzoic acid and extracted by an acetate buffer, pH
4.8. The crude extract was then fractionated with calcium 1
in 50% ethanol (v/v), followed by kaolin adsorption and
chromatography on Decaiso columns., The crude product,
having specific activity of 7,000 IU/mg, was further
purified by chromatography on Dowex 2 columns or starch
gel electrophoresis. The final product was homogeneous
as ascertained by physicochemical tests for its purity;
the hormonal activity as measured by seminal vesicle
test was 12,000 IU/mg
19
11. Method of reis field, 1960
In Nay, 1960, Reisfield Hertz (10) also purified
HCG from the urine of patients with trophoblastic
tumors, including chroiocar cinoma, hydatidiform mole,
chorioadenoma destruens, and syncytial endometritis.
The purification method involved the following
a. Kaolin adsorption yielded a product of 150-200
IU/mg.
b. DEAE-cellulose column tris -phosphate (0.005 M
phosphate-0.04 M tris) buffer pH 8.6 with increas-
ing ionic strength by adding NaC1. The hormone
was eluted between 0.01 N to 0.12 N of NaCl. The
specific activity of this product was 1500 IU/mg.
c. Further purification was performed by the same
DEAE-cellulose column in the same buffer but at
pH 6. The final step increased the specific
activity of the hormone to 10,000-12,000 TU/mg.
Howevery this final product showm three distinct
peaks when examined by moving-boundary electropho-
resis.
III. Method of Canfield, 1966
Since 1966, Canfield and his collaborators have
investigated the purification of HCG from pregnancy
20
urinc. The method described (11) was as follows: 4 g
commercial grade HCG (with biological activity of 2,500--
3, 000 IU/mg) was adsorbed to SE-Sephadex C-50 equilibratod
with 0.05 M ammonium acetate buffer pH 5. The HCG
eluted by increasing the ionic strength of the equili-
brating buffer. The active fraction was lyophilized and
passed through a second column of Bio-gel P-150 in 0.05 M
ammonium bicarbonate buffer at pH 5. The product was
further purified with DEAE-Sephadex A-50-ion-exchanger
equilibrated with 0.02 M ammonium bicarbonate buffer.
The yield of purified material from 4 g. of the crude
urinary HCG was about 400 rng. and its biological activity
was consistently between 13, 000 and 15,000 IU/mg.as
measured by-the rate of ventral prostate weight assay.
The final product showed a broad band on disc electro-
phoresis, indicating heterogeneity of the hormone.
IV. Method of Hell, 1968
In 1968 Hell et al. (12) obtained two preparations
of urinary HCG. One was highly active but showed hetero-
geneity on starch gel electrophoresis while the other
was homogeneous on starch gel electrophoresis. The
biological activity of the later was low. The method
they conducted was as follows: Commercial crude HCG with
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activity of 1.500 IU/mg was first fractionatod with
cthanol.By varying the amount of ethanol together with
ammonium acetate,acetic acid and hydrochloric acid added
into the mixture ,they obrained a crude product of specific
activity of 7.500 IU/mg. This crude product was subjected
to chromatography on CM-Sephadex equilibrated with 0.1 M
ammonium acetate buffer at PH 5. The hormone was cluted
with inereasing concentration of the buffer.The active
fraction was further purified by gel fiitration of isephadex
G-100.equilibrated and eluted with distilled water.The
final product had potency up to 18.800 IU/mg as determined
by seminal vesicle test.However,heterogeneity was shown
on starch gel electrophoresis.
V. Method of Bahl.1969
IN 1969,Bahl 8 published a paper on purification
of HCG from urine. The product obtained was homogeneous
by ultracentrifugation,disc and immunoelectrophoresis.
His method was as follows:4.84 g. of commericial HCG
dissolved in 25 ml of 0.02 M tris-phosphate buffer at
pH 8.7 and was applied a column of DEAE-Sephadex A-50
equilibrated with 0.04 M tris-phoshate buffer pH 8.7.
The hormone was eluted by a series of the equilibrating
buffers of increasing pH values and sodium chloride con-
centration in a discontinuous stepwise gradient.The
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active fraction was cluted between 0.1 M NaCl and 0.2 M
NaC1. Afterdialysis and lyophilized, the resulting
residue was rechromatographed on DEAE--Sephadex A--50
column equilibrated with 0.04 M tris-phosphate buffer at
pH 8.3 containing 0.1 M NaCl. The hormone was eluted
with a linear gradient betwwseen. 0.1 M NaCl and 0.2 M NaCl.
The major active fraction was dialysed against water and
lyophilized and subjected to further purification by gel
filtration of Sephadex G-100 with 0.04 N sodium phosphate
buffer at pH 7.5. A single peak was obtained. 4.84 g.
crude HCG yielded 0.92 g. pure protein. This final product
showed homogeneity on disc electrophoresis and with biolo-
gical activity of. 12,000 IU/mg as assayed by the rat
prostate gland method.
VI. Method of Mori, 1970
In 1970, Mori (13) reported a simple method on
purification of urinary HCG. A commercial crude HCG
with specific activity of 3,000 IU/mg was used as the
starting material.. The crude HCG was dissolved in a
small volumn of 0.02 M ammonium acetate buffer at pH 6.0
and was applied to a 2.5 x 92 cm Sephadex G-100 column.
The active fraction was, lyophilized and was further
purified by chromatography on a DEAE-cellulose column
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in 0.005 M phosphate buffer at PH 6 with gradient of
increasing NaCl concentration. The final Product has
biological activity of 12,800 IU/mg as determined by
the seminal vesicle weight method and gave a single
broad band on 6% polyacrylamide gel electrophoresis.
VII. Method of Ashitals, 1970
Ashitaka and his collaborators (14) in 1970 reported
a method to purify HCG from pregnancy urine. They reported
there were two kinds of IICG present in human pregnancy
urine. One had luteinzing hormone (LH) activity while
the other, follicle stimulating (FSH) activity. They
used the commercial I-ICG (2,130 IU/mg.) as the starting
material. The active fraction was unretarded by gel
filtration on Sephadex G-50 in 0.01 M NH4Ac buffer at
pH 6. This active fraction was subjected to CM-C chro-
matography with 0.01 M NH4-Ac buffer at pH 6. The un-
adsorbed fraction was concentrated by a rotary evaporator
and then subjected to gel filtration on Sepliadex G-100
in 0.005 M NHI1Ac buffer at pH 8.6. Three fractions were
obtained in which the LII-like HCG and FSH-like HCG was
separated. The two hormones were further purified by
chromatography on DEAE-cellulose in 0.005 M NH44Ac buffer
at 8.6. Although the final product had an activity of
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18, 000 IU/mg (for LH-like HCG) and 20.O0O IU/mg (for
FSH-like HCG) as determined by Stee1man-pohley metIxo
and the ovarian ascorbic acid depletion (OAAD) method.
They showed considerable heterogeneity on disc electro
phoresis.
In 1972, Ashitaka et al. (16) reported a similar
method of purification of HCG from hydatidif orni mole.
The crude HCG was extracted from lyophilized molar tissue
by percolation in a mixture of ethanol and sodium chloride.
Most of the biological activity was found. in the 57%
ethanol containing 5% NaCl fraction. The rest of activity
was eluted later in the 35%-5/%fraction. These two
fractions were respectively purified by:
a. gel filtration on Sephadex G-50 with 0.01 M
NH4Ac buffer at pH 6. The unretarded fraction
was subjected to
b. chromatography on CM-cellulose in 0.01 M NH4Ac
buffer, pH 6. The unadsorbed fraction was then
purified by
c. chromatography on DEAE-cellulose in 0.005 M NH4Ac
buffer at pH 8.6 with gradient elution of 0.3 M
NH4Ac buffer at pH 7.0. The active fractions
were further purified with
d. chromatography on DEAE-Sephadex A-50 in 0.05 M
tris-buffer at pH 8.6 with gradient elution of
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0.8 M tris -buffer at PH 7.2. With a starting
material of 200 g. dry tissue, 23.4 mg of HCG-LH
like protein was obtained from the 57%-5%
fraction while 9.5 ing of HCG-FSH like protein
was obtained from the 35%-5% fraction. Both the
final products showed heterogeneity on 7% poly-
acrylaccmide disc gel electrophoresis though it had
biological activity of 26,000 IU/mg and 8,600 IU/nag
for HCC-LH like protein and HCG-FSH like protein
respectively.
The above review shows that urinary HCG has been
successfully purified, particularly by Bahl et al. (15)
who have recently reported the primary structure of urinary
HCG which will be discussed later. The purification of
molar HCG, though being attempted by the Japanese group,
had not achieved the purity standard for sequence work;
N-terminal analysis, complete amino acids composition
and other properties have not yet been reported by these
authors.
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PART C. CHEMICAL AND POOYSICAL PROPERTIES OF DCG
I. The Molecular Weight
The molecular weight of urinary Hcg as dotermincd
by ultracentrifugation was as follows:
a. 46,000 (11);
b. 47.000 (8); and
c. 62,000 (12) .
Its molecular weight has been demonstrated to vary
with pHvaiues (23). I t was showed that at pH 10.2 . the
molecular weight was 61.300 while at pH 7.8, 55.000; these
were detormined by polyacrylamide gel clectrophoresis. The
molecular weight as determined by gel filtration method
yielded the following values:
a. 37,700 using sephadex g-100 (13); and
b. 59,000 ± 4000 using sephadex g-150 (8).
II. Isoelectric point (pI)
The isoelectric point (pI) of the urinary HCG was
first investigated by Hertz (10) in 1960 to be 2.95,
using free boundary olectrophoresis. However, the pI
of the urinary HCG extracted from patients of tropho-
blastic tumor was 3.8-4.0. similar results were obtained
by Hammond (23) in 1971 and Kaplan (24) in 1972 using
isoelectric-focusing polyacrylamide gel tochnique. They
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found the pI values were
3.0: HCG extracted from normal pregnant urine;
4.5: culture medium of human chorioepithelioma; and
6.0: desialic HCG
III. carbohydrates
HCG is a glycoprotein which contains about 30% of
carbohydrates. The carbohydrates of HCG consist of
n
fucose, galactose, marose, glucosarnine, galactosainine
and N-acetyl-neuraminic acid (NANA).
Table 1 shows the contents of carbohydrates in HCG;
high NANA (one-third on weight basis) is characteristic
of HCG. The carbohydrate in the HCG molecule isolated
from. the urine of the patients with trophoblastic tumor
or from the tissue of hydatidiforrn mole were found to be
as high as 50% (w/w ). The structure of the carbohydrate
moiety of HCG was proposed by Bahl (31), whose procedure
is briefly described below
HCG was desialized by mild acid hydrolysis, reduced,
with mercaptoethanol followed by carboxamidomethylations
by iodoacetamide. The resulting alkylated product was
subjected to tryptic hydrolysis. Two chrornatograp:hiicall y
homogeneous gl ycopeptides were obtained by gel filtration
on Sephadex G-50 and ion-exchange chromatography on
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Dowex I. The earbohydrate compoaition of those gly
copeptides were found to be Fucl;Cal4;Han5;clukac6 and
1 4
Gal2; man5; Glunac5 5
The sequence of these monosacharides was determined
by stepwise cleavage of the sugars from the nonroducinv
ends with specific .glycosidases, such as B-galactosidase,
B-N-acetyigiucosaulninidase, d-rnannosidase, d-L-fucosidase
and neuratAnidase n He proposed a tentative structure as
follows:
Man Man Man Man an GluNAc-protein
GluNAc GIuNAc GIuNAc GIuNAc GluNAc
Gal Gal Gal Gal Gal
N-AN N-AN N-AN Fuc
Man Man Man Man Man GluNAc-Protein
GluNAc GluNAc G1uNAc GluNAc
Gal Gal
N-AN N-AN
Table 1 Carbohydrate Content of HCG
g/l00 .g
Ashitaka (1970) Ashitaka (1970)
Hell Bahl Mori Got Hertz (1960) urinary HCG molar HCG
(1968) (1969) (1970) (1960) norm* tropho* LH like FSH like LH like FSH like
ucose 0.6 0.6 0.6 1.2
alactose 3.9 5.3 5.0 4.9
Mannzose 2.9 5.3 4.8 4.9
Total hexose 11.2 11.0 16.2. 10.0 9.6 40 28
Glucosamine 7.3 8.9 8.8 7.0
alactosamine 1.8 2.2 1.8 1.7
2.8
Tofal hexosamine 11.0 8.7 6.4 7.4 7.3 3.3
NANA 8.2 9.0 8.4 .8.5. 9.5 11.0 8.21 9.3
Total carbohydrate 24.6 31.3 29.4 28.2 26.9 27.9 51.5 40.1
norm=HCG isolated from. normal pregnant urine, tropho=HCG isolated from urine of trophoblastic tumer
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IV. Amino Acid Composition
given in Table 2. Values of the composition of the
amino acid residues were fairly consistently found by
various workers; unusually high prolino content is
detected. Due to the difficulty in isolation of urinary
HCG of trophoblastic patient or hydatidiform niole, only
the amino acid composition of that in normal pregnancy
has been ascertained. The amino acid sequence was recently
elucidated by Bahl (15) and is given in Fig. 8.
V. Subunits of HCG
Since the discovery of subunits of ovine LH (32),
subunit properties became one of the common features of
gong do trophins. In 1969, Canfield et al. (33), when
dealing with the purification of urinary HCG found that
the molecular weight of the reduced carboxyinethylated HCG.
determined by ultracent:rifuga tion method was about 26,000,
roughly one half of the native HCG. They suspected that
the HCG molecule was composed of two identical subunits.
In the same year, Bahl (8) also reported that the hormone
was composed of two subunits because the molecular weight
of carboxainido-rnethylated HCC, as determined by gel fil-
tration method, was 30,000, nearly one half of the native
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HCG. However, results of the tryptic maapping, electro-
phoretic mobilities, carbohydrate contents and amino
acid composition of the two subunits indicated that the
two subunits are not identical (8, 33) and their investi-
gations are briefly described below.
The reduced carboxymethylated. HCG subunits were
separated by preparative gel electrophoresis or by passing
through a column of Sephadex G-25 equilibrated with 0.005 M
acetic acid. The native hormone can be desociated into
subunits in 8 M urea buffered with 0.04 N tris-phosphate,
pH 7.5, incubated at 370C for one hour. The incubated
mixture was subjected to a column of DEAE-Sephadex A-50.
Two peaks corresponding to A and B subunits were obtained
(34). The two subunits gave distinct band on polyacrylamide
.gel electrophoresis and differed in amino acid composition
(see Table 3). The subunit itself has no biological acti-
vity. When the two subunits in 0.01-0.02 M sodium phosphate
buffer, pH 6.8-7.0, was incubated for 15-20 hours at 37oC,
they reassociated as evidenced by a single band on electro-
phoresis in polyacrylamide gel and, also, gel filtration
pattern on Sephadex G-100. The recombined HCG yielded
about 66% activity of that of the native hormone Very
recent result (35) showed that B-chain of HCG is hormonal
specific while the d-chain is common for gong dotrophins.
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Lysine 4.4 4.4 4.3 4.3 4.1 5.3
His tidine 2.2 1.8 1.8 1.7 1.4 1.9
Arginine 6.4 6.6 6.5 6.7 6.0 5.9
Aspartic acid 7.7 7.4 8.4 8.4 8.5 10.3
Threonine 7.7 7.3 7.5 7.2 7.9 6.8
Serine 8.5 9.5 8.4 9.2 9.1 7.0
Glutamic acid 7.8 7.9 8.6 7.2 7.8 11.1
Proline 11.9 12.2 12.6 12.1 13.0 8.1
Glycine 6.0 5.3 6.0 5.2 6.1 12.8
Alanine 6.1 5.4 5.8 05 6 5.8 6.6
Half-cystine 6.3 8.6 7.6 8.6 8.0 2.5
Val ine 7.1 7.9 7.3 7.3 7.8 5.4
Methionine 1.9 1.7 0.7 3.2 l.0 1.6
Isoleucine 2.7 2.4 2.6 2.4 2.6 2.3
Leucine 6.7 6.4 6.7 6.6 6.9 5.0
Tyrosine 3.4 2.6 2.7 3.4 4.6 4.4
Phenylalanine 3.1 2.4 2.6 2.9 2.7 2.5
Biological
Activity IU/mg
18,800 12,000 13,300 12,800 18,000 20.000
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The Amino Acid Sequence of the a-Subunit
of Carboxamidomethylated IICG
Fig. 8. The amino acid sequence of the d-subunit
of carhoxamidomethyiated HCG..
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The Amino Acid Sequence of the B-Subunit
of Cnrboxamidomothylntud HCG
Fig. 8. The amino acid sequence of the B-subunit
of carboxamidornethylated HCC.
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Table 3a Amino acid. composition- of subutlit of
HCGe
Values represent percent of the polypeptide content.
Hydrolyses were carried out for 24 hours only and
therefore no correction was made for destruction.
Tryptophan was not determined.



















7.8 3.5 5.65 5.15
3.9 1.1 2.50 2.40
4.2 10.7 7.45 9.93
7.3 9.7 8.50 8.46
8.0 6.6 7.30 7.20
7.2 7.8 7.50 7.26
12.7 8.9 10.80 9.79
6.9 13.8 10.35 11.16
2.5 3.3 2.90 2.90
3.3 3.9 3.60 3.69
9.4 7.4 8.4 8.28
7.0 6.6 6.80 6.88
3.0 0.4 1.70 2.06
0.9 2.9 1.90 2.32
4.0 8.4 6.20 6.93
5.9 3.0 4.45 4.28
5.8 2.2 4.0 3.61
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PART D. BIOLOGICAL PROPERTY OF HCG
I. Site of Secretion
Jones and Cer in 1943 (36) clearly established.,
by means of placental cell culture that the placenta
manufactured HCG. Zilliacus and his coworkers (37, 38)
using his tochernical technique, indicated that HCG could
be produced by the syncytium as well as by the Langhans
cells. Midgley and Pierce (1962) (45) could detect
positive fluorescence only in the syncytiotrophoblastic
cells, by means of a direct irnmunofluorescent technique.
Thiede and Choate (1963) (46) using a more sensitive
indirect immunofluorescent technique, found positive
fluorescence in both the Langhans and syncytiotrophblastic
cells. Brady (1969) (47) reviewed the result of tissue
culture, histochemical and immunohistochemical studies to
localize the site of production of HCG in the placenta.
In view of the above results, it may be reasonable to
suggest that HCG production starts in the cytotropho-
blastic cells and continues in the syncytiotrophoblastic
cells (48).
II. Function of HCG During Pregnancy
HCG prevents the normal involution of the corpus
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luteurnn at the end of the sexual month, iU tead, it
causes the corpus lutezliz.m to secret even larger amount of
progesterone and estrogexnsa These excess hormones cause
the uterine endormmetriuni to continue growing and to store
large amounts of nutrients. The continued secretion of
estrogens and progesterone maintains the decidual nature
of the uterine endometriuin which is necessary to the
early development of the placenta and other fetal. tissue,
In brief, HCG possesses luteining and luteotropic acti-
vities and its function is to maintain the corpus luteum
until the placenta is capable of producing estrogen and
progesterone which are necessary for the maintenance of
pregnancy (49).
III. HCG Stimulation of Biosynthesis of Steroid and Protein
HCG accelerates the biosynthesis of gonadal steroid
hormones was demonstrated in vivo and in vitro. The
increase in steroid synthesis ivras observed in different
tissue: testis, corpus luteum and ovary; from several
species: cow, rat, rabbit and human; with several substrates:
cholesterol, progesterone and radioactive acetate. The
effect of HCG on biosynthesis of androgens by the testis
in vitro was shown by Brady (50) who incubated rabbit,
hog and human testicular slices with radioactive acetate.
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The conversion of acetate to testosterone was demons
tr ated for these three species. The effect of HCG in
vivo biosynthesis of androgen was demonstrated in dog
(51, 52) and in bull (53). The biosynthesis of estrogens
by the ovary stimulated with HCG was conducted by Nyman
et al. (54) who pretreated a stallion for six days with
HCG prior to the removal of the testis, which was then
perfused for 24 hours with acetate-C14. Radioactive
estrone and estradiol were obtained from both the testis
tissue and serum. Similar work with isolated soon ovaries
resulted in the production of estrone, estradiol-17B and
cholesterol (55). The stimulatory effect of HCG on
protein synthesis was investigated in the slices of
rabbit testis. An increased rate of protein synthesis
was detected within 20 minutes after addition of hormone
to the medium (56).
IV. Mechanism of HCG
The mechanism of HCG action on ovary, testis and
corpus luteum is not well understood. However, certain
results merits to mention which may lead to the under.
standing of the mechanism of HCG. Brady (50) in the
study with tissue slices and radioisotopes, indicated
the pathway of HCG: stimulated steroidogenesis did not
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involve chole sterol, i.e., from acetate to pregnenolone.
In the slices of rabbit testis an increased rate of
protein synthesis was detected within 20 minutes prior to
detectable increase in steroidogenesis. It was also
observed that the incorporation of radiolabled acetate
into testosterone was prevented by chioramphenical and
puromycin (a known inhibitor of protein synthesis). Thus,
it appeared that the steroidogenesis stimulated by gonado-
trophin was related to or probably depended on protein
synthesis (56). It was also found that the steroid..
biosynthesis could be affected by the cofactor NADPH
(57, 58, 59). Based on the above observations, two
mechanism of gonadotrophin on steroidogenesis were
proposed (60). The first involved the stimulation of
metabolic systems for the rapid generation of reduced
NADP. This compound could then act to stimulate con-
version of cholesterol or similar substrates to steroid
hormones. The second mechanism might involve the acti-
vation of a pathway involving the utilization of small
molecular precursors such as acetate for steroid synthesis.
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Table 4 Flow Chart of the Fractionation of Molar HCG
5 g dry tissue.
500 ml 0.15 M (NH4)2So4, pH 4/1 N HCl stir overnight
Centrifuge at 10,000 x g 20 mins
Supernatant (CS-1) PPT discarded (CP-l)
pH 3/0.5 M H3P04
Centrifuge at 10,000 x g 20 minx
Supernatant (CS-2) PPT discarded (CP-2)
Half saturation of (NH4)2S04 stir 2 hours
Centrifuge at 1O,000 x g 30 mins
Supernatant(CS-3) PPT (CP-3)






Sepha.d.ex G- 200 chromatography: in 0.05 M NH4HC03
G-240-1 G-200-2 G-200-3
Lyoplilize
DEAR Sephadex A-50 chromatography in 0.04 M tris-phosphate
pH 8.6 with increasing ionic strength by adding NaCl
DE-1 DE-2 DE-3 DE-4 DE-5 DE-6 DE-7
dialysis against, 0.01 H NH4HCO3 24 hours





M E T H O D A N D MATERIALS
PART A. FRACTIONATION OF HUMAN CHORIONIC GONADOTROPHIN
The stepwise procedures were shown in Table (see
p. 110, 41) and the details, described below. All
chemicals used. were of analytical grade except those
otherwise specified. The gel filtration was carried
out in LIMB fraction collectors of the following models:
a. Ultrorac 7000, with refrigerated compartments
adjusted to 4°+1°C.
b. RadiRac 3400B placed in a cold room at, 5o+1oC .
I. Salt Precipitation
The molar tissue was delivered to the laboratory
within two hours after hysterectomy. The tissue was
carefully washed with cold 0.9% NaCl solution to remove
blood. It was homogenized for three times in a Waring
blender kept at 4°C, blending for one minute each time,
and then lyophilized.
Five Hof the dry tissue was suspended in 500 ml of
0.15 M ammonium sulphate solution. The suspension was
adjusted to pH-H 4 by addition of 1 N HC1 and was stirred
overnight at 4°C. The mixture was centrifuged at 10,000
x g for 20 minutes and the cell debris (CP--1) was dis-
carded. The supernatant (CS-1) was then adjusted to
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pM 3.0 with freshly prepared 0.5 M H3PO4. After
centrifugation again at 10,000 x g for 20 minutes, the
precipitate (CPry-2) was discarded. The supernatant (CS-2)
was half saturated with ammonium sulphate. It was then
stirred for two hours before centrifugation at 10,000
x g for 30 minutes. The precipitate (CP-3) was dissolved
in 100 ml of 0.2 M K2HP04 solution and dialysed against
running cold water for one day. The supernatant (CS-3)
was then fully saturated with ammonium sulphate and treated
similarily as before. The precipitate (CP-4) was dissolved
in 100 ml of 0.2 M K2HPO4 solution and dialysed against
running cold water for one day. The supernatant (CS-4)
was also dialysed against running cold water for one day.
After dialysis, the pH of (CP-3), (CP--.4) and (CS-4) were
adjusted to 8.5 with 1 N NaOH and any precipitate' formed
during dialysis was removed by centrifugation at 10,000
x g for 10 minutes. The supernatants (CP-3D), (CP-14D)
and (CS-4D) were lyophilized respectively.
All the fractions obtained from the above procedures
were assayed by immunoassay and their protein contents
were determined by Folin-Ciocaltue method (61).
The (CP-3D) fraction was subjected to Sephadex G-200
chromatography.
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II. Sephadex G-200 Chromnatoraphy
The gel-filtration described below was carried out
at 5o±l°C.
Sephadex G-200 (Lot No. 111C-0460, particle size
40-120 mesh, Pharma c is Fine Chemicals, Sweden) was soaked
in 0.05 M NH4IICO3 buffer containing 0.02% sodium azide
in a boiling water bath for seven hours and was allowed
to stand overnight at room temperature. The slurry,
after removal of a±r, was packed into a column (2x 150
cm) by means of a funnel. The column was thoroughly
equilibrated with 0.05 M NH1}HCO3 buffer containing 0.020,0
sodium azide before use. The void volume was determined
by 0.2% of blue Dextran 2000 (Lot No. 11OC-1770, Sigma
Chemical Co., U.S.A.) in 0.05 M NH4HCO3 buffer. The
sample size of the blue dextran was 1% of the bed volume.
Approximately 500 rng. of the crude product (CP-3D) was
dissolved in the buffer and applied to the column.
Elution was carried out with the equilibrated buffer
at a flow rate of 10 ml.per hour and each fractions
contained 5.5 ml. All the elution volumes were determined
by the apex of the absorbance profile. Blue dextran was
read at 630 nm and the protein solution was read at 280
nm (Beckman 109200 Model DU-2 Spectrophotometer). The
hormonal activities and protein contents of the fractionated
eluents were determined before being lyophilized.
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III, DEAE Scphadex A-50 anion-exchange chromatography
The DEAE Sephadex A-50 (diethylaminocthyl deri-
vative of Sephadex, particle size 40-120, capacity
3.5±0.5 meq/g, Lot No. 97B-0370, Sigma Chemical Co.,
U.S.A.) was soaked in 0.04 M tris-phosphate buffer at
pH 8.6 in a boiling water bath for three hours. It was
then cooled overnight at room temperature. After removal
of air present in the slurry, it was packed into a jacket-
column (2 x 30 cm) kept at 4°C, which was thoroughly
equilibrated with the buffer for 2 days before use.
About 100 tug of fraction G-200--2 were dissolved in
5 ml of the tris-phosphate buffer. The sample solution
was dialysed against the same buffer for 24 hours at 4°C.
Any precipitate formed was removed by centrifugation
before being applied into the column. The elution of
the column was initiated with 50 ml of the tris-phosphate
buffer at pH 8.6, followed by increasing NaCl concen-
tration in the following manner:
a. Chamber A: 100 ml of 0.04 M tris-phosphate
buffer pH 806;
Chamber B: 100 ml of 0.04 M tris-phosphate
buffer pH.8.6+ 0.2 M NaCl;
b. 200 111l of 0.04 M.tris-phosphate buffer pH 8.6
+ 0.2 M NaC1.
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5-m1 fractions were collected by the LKB-U1trorac with
the flow rate roughly 40--50 ml per hour. The protein
solution was read at 280 nin by LKB 8300 UV Cord II and
recorded by LKB 6520 Chopper Bar Recorder. The fractions
collected were dialysed against 0.01 M NH4HCO 3 solution
at 4°C for two days. The activities and protein contents
of these fractions were determined before being lyophi-
lized. Fractions in the first peak were pooled and
further purified by Sephadex C--100.
IV. Sephadex 0-100 Chromatography
Sephadex C-100 chromatography was performed at
room temperature (22°±2°C) but the eluted fractions
were collected in a cold compartment adjusted to 4°C
in an LIMB Ul trora c. S epha dex C-100 (Lot No. 6164,
particle size 40-120, 4, Pharmacia Fine Chemicals, Sweden)
was swollen with 0.05 M NH4HCO3 buffer containing 0.02%
sodium azide in a boiling water bath for five hours. It
was then left overnight at room temperature. The slurry
after removal, of air was packed into the column (1.4 x
28 cm) by means of a funnel. The column was thoroughly
equilibrated with 0.05 M NH4HCO3 buffer containing 0.02%
sodium azide before use. The void volume was determined
by 0.2% of "Blue Dextran 2000" (Lot No. 11OC--1770, Sigma
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Chemical Co., U.S.A.) in 0.05 M NH4HCO3 buffer. The
sample size of the blue dextrin was 1% of the bed volume
About 10 mg of the sample dissolved in 0.4 tmml of the
buffer were applied into the coltu.mn. Elution was carried
out with the equilibrated buffer and was conducted by a
fraction collector (LKB Ultrarac Model 7000) at a flow
rate of 14 ml per hour and two-ml fractions were collected.
The absorbance profile of the blue dextran and protein was
read by LKB 8300 UV Cord II at 280 nm and recorded by
LKB 6520 Chopper Bar Recorder. All the activities and
protein contents of the. fractionated eluents were deter-
mined before being lyophilized.
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PART B. PROPIILTIES OF HUMAN CHORIONIC GONADOTROPHIN
I. Immunoassay
The commercial immuno-HCG kits were used during the
purification process. One is UCG titration test (Warnpole
Laboratories, Stamford, Conn., U.S.A.) with a stated
sensitivity of 0.8 lU/ml. The other is Pregnosticon
Planotest (Organon Inc., U.S.A., West Orange, N.J.,
U.S.A.) with a stated sensitivity of 2.5 lU/ml.
The potency of the hormone was calculated by serial
dilution until the end point was reached. The diluent
composed of 0.9% NaCl, 0.1/ bovine serum albumin (BSA).. and
0.01 M Na2HPO4 buffer, pH 8. The procedure of the UCG
titration test was as follows:
a. addition of 0.25 ml diluted sample solution
into a l x 7 cm test tube;
b. addition of 0.25 ml anti serum, before mixing;
P. addition of one drop of red blood cells coated
with HCG, followed by mixing;
d. standing vertically for two hours, undisturbed;
e. a brown ring at the bottom of the tube indicated
a positive result.
The procedure of the Pregnosticon Planotest was:
a. one drop of sample was mixed with one drop of
anti serum on a clean glass plate;
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b. after 30 seconds, one drop of latex solution
sensitized with HCG molecules was added;
c. the mixture was spread and mixed and the result
was read after two minutes;
d. no agglutination present in the mixture indi-
cates a positive result.
II. Elution Pattern of the Final Product in Sephadex
G-100
This followed exactly as given in Part A IV, p. 46.
III. Electrophoretic Pattern in Pol acrylamide Gel
The disc electrophoresis was performed following
the method of Davis (62) with slight modifications. For
high pH, a 7% gel, stacked at pH 8.9, was prepared one
hour before use. For low pH, a 7.5% gel, stacked at pH
5.0 was prepared similarly. The column dimension was
0.5 x 7 cm. The sample size was about 100ug of protein
per column dissolved in 0.1 ml of l0% sucrose solution.
The electrophoresis was carried out at room temperature
(22°C) at a constant current of 3 mA per tube for about
two hours until the tracing dye had reached the end of
the column.
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The method is described in brief as follows
a. Stock solution for high pH
1. 1 N HCI 24 m1
Tris (Hydroxymethyl.) aminomethane 18.1 g
TEMED (N,N,N', N', Tetramethylethy-
lenediamine 0.12 ml
Water added to 100 ml and pH adjusted
to 8.8-9.0
2. 1 N HCI 4 8 in1
Tris 5.98 g
TEMED o.46 ml
Water added to 100 ml and pH adjusted
to 6.6-6.8
3. Acrylamide 28 g
Bis (N,N'-methylenebisacrylamide) 0.735 g
Water added to 100 ml
4. It. Acrylamide 20 g
Bis 5 g
Water added to 100 ml
5. Riboflavin (kept away from light) 4 mg
Water added to 100 ml
6. 40% sucrose
7. Ammonium Persulfate 0.14 g
Water added to 100 ml
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8. Electrophoretic tank buffer
Tri.s 3 g
Glycine 14.1 g
Water added to 1000 ml
9. Staining solution
0.05% Amido Black 10 B in 7% acetic acid
10. Tracing dye
0.005% Bromphen l Blue in water
b. Working solutions for high pH were prepared by
mixing the stock solutions in the following amount:
1. The separation gel solution
a-1: a-3: a-7 = 1 : 1 : 2 (v/v)
2. The stacking gel solution
a-2 : a-4 : a-5 : a-6 : H20 = 1 : 1 : 1 : 4 : 1 (v/v)
3. Rinse solution
a-2 : a-5 : H2O = 1 : 1 : 6
c. Stock solutions for low pH
1. 1 N KOH 48 ml
Glacial. acetic acid 17.2 ml
TEMED 4 ml
Water added to 100 ml and pH adjusted
to 4.3
2. 1 N KOH 48 ml
Glacial acetic acid 2.87 ml
TEMED 0.46 ml




3. Acrylaniide 30 g
Bis 0.8 g
Water added to 100 ml
4. Ammonium Persulphate 0.28 g
Water added to 100 ml
5. Electrophoretic tank buffer
Beta alanine 31.2 g
Glacial acetic acid 8 ml
Water added to 1000 ml
d. Working solutions for low pH
1. The separation gel solution
c-1: c-3: H2O: c-4_ 1: 2: 1: 4 (v/v)
2. The stacking gel solution
c-2: a-4: a-5: H2O 1: 1: 1: 5 (v/v)
e. Procedure
The separating gel solution was added into the
column. 0.2 ml water was then added on the surface
of the gel solution. It was polymerized by the
chemical catalysis of ammonium persulphate. After
the gel was set, the water on the surface was
removed. 0.2 ml light-sensitive stacking gel
solution were added and polymerized photochemically
by means of a florescence light. The concentrated
solution made during the polymerization was washed
with the rinse solution and the columns were fixed
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in the electrophoretic tank (Canalco Model 12,
Canalco Industrial corporation, 5636 Fisher Lane,
20852, U.S.A.)with stacking gel at the cathode
end. A fow drops of tracing dye solution was
added into the buffer. Tho sample was applied
to the cathode side of the column. Aftor electro-
phoresis, the gol was taken out and stained in
Amido Black 10 B solution for two hours. The gel
was destained overnight with 7% acetic acid
IV. electrophoretic pattern in starch gel
The starch gel electrophoresis was performed follow-
ing the method of smithies (63). The starch gel was
obtained from British drug House (BDH), poole ,England.
8.9 g . of the starch per 100 ml buffer solution were
used. The gel bufer contained 0.0215 M boric acid and
0.0086 M sodium hydroxide per litre solution. The pH of
the gel medium was 8.5. The bridge buffor contained 0.3
M boric acid and 0.06 M sodium hydroxide per liter solution.
The EEL clectrophoresis bath (Evans Electroselenium Ltd.,
England) was used. The tray dimensionsmeasured 18.5×5
×0.6 cm . The electrophoresis was performed at room
temperature (22±2c) and the protein samplc aplied to
the starch gel was not more than 0.2 mg per each samplc
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slot. The staining solution was prepared. by mixing
100 mg, Nigrosine, 200 mnl ethanol, 50 ml 25% trichioro-
acetic acid and 500 ml distilled water. The, potontial
applied during electrophoresis was kept constant at 5
volts per cm length of the starch gel.
The starch gel was made following the detailed
procedure described by 1. Smith (64). 8.9 g. of starch
gel was mixed with 100 ml of gel buffer in a Pyrex suction
flask connected to a vacuum line. It was heated uniformly
over a gas burner with vigorous swirling until the mixture
was translucent. After removing air by suction, the trans-
lucent liquid was decanted into the tray immediately, kept
cool for two hours at 14°C before use. The sample protein
was dissolved in the gel buffer. A small piece of Whatman
No-'3 filter paper (0.5 cm x 1.5 cm) soaked with the protein
solution was applied to the gel. After the electrophoretic
run, the gel was sliced into 3 pieces (2 mm thickness) and
stained with Nigrosine for overnight. It was then destained
with 5% trichloroacetic acid until the background was clean.
The pattern is shovm in Fig. 17
V. Molecular Size Determination (M.W.) by Se,pliad.ex G 200
Sephadex G-200 (Lot No. 118B-0330, particle size
l0-40, Sigma Chemical Co., U.S.A.) was swollen with
0.05 M NHIlHCO3 buffer containing 0.02% sodium azide in
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in a boiling water bath for seven hours (65). 1_t was
then left overnight at room temperature. After removal
of air the slurry was pace- into the standard Pharmacia
columns (2.3 x 30 can) at 22±10C- and maintained at this
temperature throughout the procedure. The column was
thoroughly equilibrated with 0.05 M NI-141UC03 buffer
containing 0.02% of sodium azide. Blue Dextran was used
to check the effectiveness of the column and also its
void volume was determined. The known protein markers,
shown belowr, were obtained from Schwarz/Mann Chemical
































About 3-5 tui,f of each protein was d.isso -Ve-.d in. 2
ml of the equilibrating buffer and the total amount of
protein applied to the column did not exceed 20 mg.
Elution was carried out with the equilibrating buffer
at a flow rate-of 6 nil per hour and 3-m1 fractions were
collected by an LKB Ultrarac. The optical density of
the eluent s was read with Beckman DU-2 spectrophotometer
and the elution volume of each protein was determined by
the apex of the absorbance profile.
VI. Isoelectric Point Determination- Isoelectrofocus
The isoelectric point (pI) of the purified HCG sample
was determined by means of isoelectrofocusing technique
as described in the instruction manual of LKB 8100 Ampholine.
All steps were operated at 4°C. An LKB 8100 isoelectro-
focusing column with capacity of 110 ml was used. The
column containing the sample and 1% ampholine of pH values
ranged from 3-10 was stabilized by sucrose density gradient
with anode on the top and cathode at the bottom.








The cathode solution was carefully transferred
to the bottom of the column. The ampholine-sucrose
gradient was developed by means of an LKB model
8101 gradient mixer. The light and dense solution
was poured into the chambers of the gradient mixer
and the flow rate was maintained at 4 ml/min by an
adjustable screw clamp. The gradient was terminated
when the level of the solution inside the column.
rose to approximately 1 cm below the upper electrode,
The anode solution was then added. The isoelectro-
focusing was started at an initial voltage of 300
volts, the power should not exceed 2.5 W during







Ampholine 40% 0.7 ml
Sample in H2o
50 ml









dropped to 0.05 A%T which took about two days T e con tent
in the column after isoelectrofocusing was eluted by LKB
Ultrorac at a flow rate of 50 nil per hour, by means of a
flow rate regulator, 3-ml fractions were collected and
its optical density at 280 mm was read by LKB 8300 UV
Cord II and recorded by LKB 652 Chopper Bar Recorder
The pH of the fractions was determined by a pH meter
(Beckman Zeromatic II model) with a combined electrode
(Beckman 39183 Probe Combination GP glass electrode),
The pH meter was calibrated against standard 4.01 buffers
before the measurements were* made at 4°C.
VII. N--terminal Determination- Dansylation Method
The N-terminal amino acids of the purified HC0 was
determined by dansyl chloride procedure (66). About 0.5
mg of protein was dissolved in 0.5 ml of 8 M urea solution
(ammonia free), buffered with NaIHCO3 (0.5 M). To this
solution, 0.5 cnl strong dansyl chloride solution was added
(20 mg per ml acetone). The mixture was left overnight
at room temperature. After reaction, the acetone in the
mixture- evaporated under reduced pressure by means of a
water suction. Traces of precipitates formed were removed
by centrifugation. The solution. was then desalted by gel
filtration with the aid of Sephadex G-25 (1 x 30 can) using
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distilled water as eluant. The diluted dan sir .-protein
was dried in a desiccator containing P205. About 50 jt1
of constant boiling HC1 (about 6 N) was used to hydrolyse
the dried protein samples The mixture was then sealed
under vaccurn and placed in an oven at 110=1 c for 16
hours o After hydrolysis, the sealed tube was opened and
dried in a desiccator containing NaOH pellets. The
dansylated N--terminal amino acid was determined by thin
layer chromatography of polyamide sheet (15 x 15 cm,
Cheng Chin Trading Co., Taipei, Taiwan) and by high
voltage electrophoresis
a. Thin layer chromatography of polyamide sheet
The dried hydrolysate was dissolved in 10
u 1 of a mixture of acetone and acetic acid in a
ratio of 3:2 (v/v) and was applied to a polyamide
sheet. The solvent system for the first dimension
was 90% formic acid and water in a ratio of
1-5:100 (v/v). The solvent system for the second
dimension was benzene and acetic acid in a ratio
of 9:1 (v/v). After the second development, the
control dansyl amino acids were applied to the
polyamide sheet at an appropriate position. The
polyamide sheet was run at a third dimension with
solvent system containing ethylacetate, methanol
and acetic acid in a ratio of 20:1:1 (v/v).
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b. High voltage paper electrophoresis
High voltage paper electrophoresis was done
following the method described by Gray (66).
Wha tmnan No. 3 filter paper (3 mm thi.cki-i.e ss) was
cut to.the dimension of 10 cm x 60 cm. The hydro-
lyzate and the known dansyl derivatives of amino
acid was applied to the paper as compact as
possible. The paper was then wetted with 8% formic
acid at pH 1.9. A flat-bed type high voltage
electrophoresis apparatus (Model L24, Shandon
Scientific Co., Ltd. London.) was used. The
electrophoresis was performed with electric field
gradient of volts per cm length of paper. for
two hours at 20°C. After the electrophoretic run,
the paper was dried quickly in an oven at 120°C.
The dried paper was exposed to ammonia fumes before
being visualized under UV light. The dansylated
N-terminal amino acids were identified by comparing
the position in the paper of the unknown sample
with the standard.
VIII. Sialic Acid Determination
The thiobarbituric acid assay of sialic acid was
firstly proposed by WvTaravdekar and Saslaw (67) in 1957.
The method used was .modified by Warren (68). The
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N-acetyl-neuramin.i c acid and the 2--th_Lobarbitu.r. ic. acid.
(41 6-Dih)rdr. oxy-2.-thropyrimid.ine) wwwrere obtained from
Sigma Chemical Co., U.S.A.
Reagents:
1. Sodium, periodate (meta) 0.2 M in 9 M phosphoric
acid.
2. Sodium arsenite, 10% in a solution of 0.5 M
sodium sulphate-0.1 N H2SO4.
3. 2-thiobarbj4-uric acids 0.6% in 0.5 M sodium
sulphate.
The procedure was as follows.- About 0.5 nag of the
sample protein dissolving in 0.1 N H2SO4 was incubated
in a water bath at 80°C for one hour. The above sample
solution was then added 0.1 ml of the periodate solution.
The tube were shaken and allowed to stand at room tem-
perature for 20 minutes. One ml of arsenite solution
was added and the tube was shaken until the yellow-brow:rn
color disappeared. 3 ml of 2-thiobarbituric acid solution
was added. After shaken and capped with a rubber stopper,
it was heated in a boiling water bath for 15 minutes.
After cooling with tap water for five minutes, 4.3 nil
of cyclohexanone was added. It was shaken twice and
centrifuged at 3,000 rpm in a clinical centrifuge for 3
minutes. The optical desnity at 506 niu of the cyclohexanone
layer was read with a spectrophotorazeter (Beckman Model DU-2).
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The calibration curve was performed simi_iariy- as the same
time using the known amount of N-acetyl-neuraminic acid
(Mot No. 91C-2830, Sigma Chemical Co., U.S.A.) as the
standard.
IX. Amino Acid Com ositi on Determination
The amino acid residue determination was kindly
performed by Professor C.H. Li (Hormone Research Laboratory,
University of California, Berkeley, U.S.A.) and Professor
Tung-bin Lo (Department of Chemistry, National University
of Tai Wan.)
X. Absorption Spectrum
The final product was dissolved in 0.05 M NH4 HCO3
buffer. The absorption of the solution from 700 mmn to
250 nm was determined with a double beam spec trophoto--
meter (Jasco Model ORD/CD-5, Tokyo, Japan.) using 0.05 M
NH4HC03 as references. The quartz cell with cell length
of 1 cm was used. The operation was performed at room
temperature (22+1c).
XI. Heat Stability
The effect of heat on molar. HCG was examined: IICO in
0.2 M K2HPOit buffer was allowed stand at 57°1°C for
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several time intervals .Immediately after heating,an
aliquot of the solution was chillcd in ice-cold water.
The cooled aliquot was diluted with 0.9% NaC1 containing
0.1% bovine serum albumin and the total activity of the
diluted solution was determined.
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R E S U L T S
PART A, FRACTIONATION OF HUMAN CHORtIONIC (IONA1)0 IROPIIIN
I. Salt Prec ination
Table 5 summaries the results obtained by means of
salt precipitation of the protein hormone. The activity
recovered in the crude preparation after dialysis (CP-3D)
amounts to 50% and its yield is approximately 10% on dry
basis. The crude preparation so 'obtained is white and
highly hydroscopic o
Table 5 HCG Activity& Protein Content of Fractions



























Fig. 9. Elution pattern of the crude preparation
(CP-31)) on Seplhaclex G-200 column (2 x 150
cm) in. 0.05 M NI-111 HCO3 buffer(---) is
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II. Sehadex 6--200 Chromography
210 mg of the above crude preparation (CP-3D) was
applied to Sephadex C-200 column. Its elution pattern
is shown in Fig. 9. Three major peaks resulted. The
fractions, as shown by the hormonal activity curve (see
Fig. 9), were separately pooled and were designated as
G-200-1, G-200-2 and G-200-3. The yields and activities
of these three fractions were summarized in Table 6.
The recovery of activity of Fraction G-200-2 is 68.4%
and its yield is approximately 37.6% on weight basis.
Table 6 HCG Activity& Dry Weight of Fractions C-200-1,















Fig. 10. Elution pattern of fraction (1-200-2 on
DEAE Sephadex A-50 column (2 x 30 cm)
equilibrated. with 0.014 I'1 tris-phosphate
buffer pH 8.6. The col-Limn was eluted. with
increasing the NaCl concentration of the
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III. DEAE Sephadex A-50 Anion-Exchange Chromatography
The elution profile of the DEAE Sephadex A-50
chromatography was shown in Fig.10.Most of the protcin
was eluted between 0.1 M Nacl to 0.2 M NaC1 contained in
0.04 M tris-phosphate buffer at pH 8.6. There were seven
major fractions designated as DE-1,DE-2,DE-3.DE-4.DE-5.
DE-6 and DE-7.which were assayed after dialysis in 0.01 M
NH4HCO3 solution for two days.The results are shown
in Table 7. It was found that the active fraction came
out at the very beginning (i.e.Fraction DE-1).The
recovery of activity of Fraction DE-1 is 62.5%,and its
yield is 8% on weight basis.
Table 7 The Activities and the Protein Contents of






































Fig. 11. Elution pattern of fraction DE-1 on Sepadex
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IV. Sephadox G--100 Cj-).rOrj--jZjtOg raphy
Three fractions designated as G-100-1, G-100-•2,
G-100-3 were obtained after the Sophaadex G-100 chronia to--
graphy as shoiNn in Fig. 1.1. Table 8 summarized their
activities and' protein contents. G--100-2 exhibited the
highest hormonal activity. The void volume as determined
by Blue dextran was 13 nil (Fig. 12). The recovery of
activity of Fraction G-100-2 was 98.8% and its yield
was 66% on the dry weight basis.
Table 8 HCG Activity& Protein Content of



















Table 9 Imrnuno-Actvity of HCG in. Various Fractions
During the Isolation, Five g of Dry Tissue























































































PART B. PROPERTIES OF HUMAN CHOR ONIC GONAD OTROPI-HIN
I. Immunoassay
The immunoac tivi ty of the final product together
with all the fractions obtained during purification.
were determined and summarized in Table 9. All the
values shoivn were calculated as percentage of acti-
vities present in 5 g dry tissue, the starting material.
The activity recovered in the final product 0-100--2
amounts to l9.7% .
II. Elution Pattern of the Final Product in Sephadex
G-100
About 5 mg of the final product G-100-2 were
applied to the Sephad.ex G-100 column. A symmetrical peak
was obtained and is shovrn in Fig. 13. The elution
volume of the final product on this column was 21_ ml.
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Fig. 13. Elution pattern of the final product
0--100-2 on Sephadex G-100 column











Fig. 14. The electrophoretic
patterns of the final product
and certain fractions on 7% poll
acrylamide gel at pH 9.
Fig. 15. Disc electrophoresis
of molar HCG on 7% polyacry-
lam:i de gel pH 9 and 7.5%
polyacrytannide gel pH 5
CP-3DG-200-1G-200-2G-200-3 DE-1 DE-2




ITT. Elect_rohoretic Pattern in Polyacrylamide Gel.
The el ectrophoretic pattern of all the fractions
obtained during purification on 7% pol.yacrylamide gel
at pH 9 were shown in Fig. 14. The final product on
7% polyacrylamide gel,- pH 9 and on 7.5% polyacrylamide
gel, pH 5 were shown in Fig. 15. Activities in the
gel were determined as follows: The gel was frozen in
a deep freezer (--4--0°C) after electrophoretic run. It
was then cut into 13 sections, each section measured
5 min long. The sections were placed into a small test
tube. and grounded with a small glass rod. 1.2 inl
diluting mixture (0.9% NaCl+ 0.1% Bovine serum albumin)
were added into the test tubes. After standing at 4°.C
for two hours, the gel was removed by centrifugation
and the supernatant was assayed. Fig 16 displays the
schematic diagram showing the result of the experiment.
The activity located correlate with the band position
of the final product in- the gel; hence there is good
agreement between the HCC activity and the protein band.
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Fig. 16. The schematic diagram showing the activity












Fig. 17. Starch gel electrophoresis of the final
product G-l00-2, and fractions CP-3D,




1. V Electro adoJr~eta_c I'iAttex-nin Starch Gel
The electrophoretic patterns of the crude
preparation (CP-3D) Fraction. G-200-2, Fraction DE-1
and the final xoduc t G-100 -2, were also examined on
starch gel and 'are shown in Fig. 17. The CP-31) showed
four smear bands on starch gel electrophoresis.
Fraction G-200-2 composed of two major bands and a
smear band. In Fraction DE-1, only two bands were
observed, one of which is HCG band. The final product
G-100-2 showed a single band on starch gel electro-
phoresis.
V. Molecular. Wei ht Determination (M.W.) by Sephadex
G-200
A linear relationship between elution volume (Ve) of
a known protein and its molecular weight in logarithm
value was obtained (Fig. 18). The apparent molecular
1weight of the molar HCG. was estimated to be 603 x 10}.
The Stokes radius of the molar HCG was 311.5 X as deter-
mined by a plot of K 1f3 av vs Stokes radius of known
samples (Fig. 19). The elution volume of the sample,
the void volume of the column and other parameters are
summarized in Table 10.
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Fig. 18. A plot of the elution volumes against the
values of the log M.W. of the known proteins
and the molar IICG on Sephadex G--200 column
in 0.05 M NH4HCO buffer. The molecular
























Fig. 19. plot of Kav 1/3 value against the Stokes
radius of the- kno-w ,Tn proteins and the molar


























Table 10 Parameters of the Known Proteins Obtained from Gel
Filtration of Sephadex G-200 in 0.05 M NH4HCO3 Buffer
Molecular v V 1/3 Ve-Vo 1/3
Protein Weight log M.W. Ve Ve Kav= e o Kav KD stoke
(M.iv.) Vt-vo redius
(A)
Bacitracn 1.450 3.16 216.6 3.11 0.95
Cyto chrom C 12, 400 4.09 186.9 2.68 0.7666 0.915 0.79 0.92 17
Myoglobin 17,800 4.25 171.9 2.47 0.6686 0.874 0.69 0.88 20
Chyrnotrysinogen 25,000 4.4 159.9 2.3 0.5901 0.839 0.61 0.85 22.3
Ovalbuinin 45,000 4,65 131 1.88 0.40 0.737 27.2
Albumin 67,000 4.83 111 1.6 0.2705 0.646 0.28 0.65 35
Y -globulin 160,O00 5.2 90 1.3 0.13 0.506 0.14 52
Apo-Ferritin 480,000 5.68 75 1.08 0.0352 0.327 0.04 0.33 79
Dextran Blue 2,000,000 69.6(vo) 1
Vt= 222.6 ml


















Fig.20.Electrofocusing of molar HCG in ampholine
of pH gradien(3-10). The upper curve
is the pH gradient curve;The
lower is the absorption curve
with sample, absorption curve
without sample.
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VI.Isoelctric Point(PI)Determination - Isoelectro-
focusing
After electrof ocusiiig for 3111 days$ the contents in
the electrofocusing column were eluted by a flow rate
regulator. The optical density (O. D.) at 280 run and,
the pH values of each tube were measured. The result
was shown by ploting the O.D. and pH values against
the tube number (Fig. 20). The intrinsic absorption
at 280 nm of the ampholine after electrofocusing was
determined under the same condition. This result served
as the electrofocusing background (see bottom line in
Fig. 20), After cancellation of the background of the
ampholine, a single peak corresponded to the absorption
of the molar HCC was observed (see Fig. 20). The pI of
the molar HCG as determined by the apex of the peak and
the pH curve was 4.2±0.1.
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Fig. 21. Two dimensional chromatogram of standard

































VII. N-tern-iiizal Deterrn:[nati.on-Dansy ation Method
Fig. 21 shows the chromatogram of the known dansyl
amino acid standards after two dimensional chromato-
graphy on polyamide sheet (142). Fig. 22 is chroniagrain
of the protein hydrolysate. There were only two spots
of dansyl amino acid representing the N'terminal amino
acid of molar IICC. By comparison with the standard
polyamide sheet, the spot marked "B" may be Ala, and the
spot marked "A" may be Ser. The standard dansyl-Ala,
was then applied to the polyamide sheet beside the spot
"B", and the standard dansyl-Ser was applied besided
the spot "A", After the third dimensional chromatography,
it was found that the standard dansyl-alanine run parallel
to the spot "B"; and dansyl-serine, to spot "A" (Fig. 23).
Hence, the molar HCG molecule must be composed of two
polypeptide chains with N-terminal amino acids of
Alanine and- Ser* ine.
The result of high voltage paper electrophoresis is
shown in Fig. 214. Only dansyl-Ala and dansyl-Ser were
observed and they were identified by comparing with the
standard dansyl-amino acids run side-by side under the
same condition.
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Fig. 22, Two dimensional chromatogram of the sample
hydrolysate on polyamide sheet. The known














Fig. 23. The third dimensional chromatogram of












Fig. 24. Electrophoretic mobilities of known dansyl
derivatives. and the sample hydrolysate at






























































































VIII. Sialic Acid Determination
Table 11. shovai the sialic acid content of fraction
CP-3D, G-200-2 and 0-100-2. It was found that the
sialic acid content increased as the fraction became
more pure. The sialic acid content of the final product











IX. Amino Acid Composition Determination
The amino acid composition of the final product
was performed, through the kind arrangement of Professor
C.H. Li (Hormone Research Laboratory, University of
California, San Francisco, U.S.A.) and Professor Tung-bin
Lo (Department of Chemistry, National University of Taiwa.n).
The result are shown in Table 12,
X. Absorption Spectrum
About .2.64 mg dry weight of molar HCG was dissolved
in 9 ml 0.05 M NH4HHCO3 buffer. The absorption of the
solution from 700 nm to 250 nm was determined and the
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Fig. 25. The spectral curve of the molar. HCC












result was shown in Fig. 25. It had only a single
absorption peak in the ultra violet region with absorp-
tion maximum at 279 nm; no absorption was detected in
the visible region,
XI. Heat Stability
The heat stability of the molar I CG was determined:
The results are summarized in Table 13. The hormone
retained its immunoactivity within five minutes at 57°
1°C; the immunoactivity decreased upon prolonged incu-
bation. Only 25% of original activity retained after 90
minutes of'incubation at above condition.






















F26. A plot of HHCG activity against the percentage
of the saturation of arilmoni_urn sulphate. Most
of the activity was achieved with 50% satura-
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D I S C U S S I 0 N
PART A. FRACTIONATION OF HUMAN CHORTONIC GONADOTROPHIN
I. Salt Precipitation
It is assumed that most HCG was extracted with 0.15 M
ammonium sulphate at pH 4 for overnight. The activity
of the extract was therefore taken as the total. activity
of the starting material. There was no loss in total
activity after the treatment of phosphoric acid at pH 3
while most blood pigments were removed.
The total recovery of activity after the salt preci-
pitation of ammonium sulphate was about 70%. The loss of
the activity was probably due to the denaturation of the
hormone during the precipitation and dialysis even though
precautions were taken to avoid the loss. Assay had been
done before and after dialysis. It was found that after
dialysis the total activity of the fractions decreased
while their specific activity, unchanged. This may
suggest that the loss was attributed to denaturation of
the hormone.
we have also investigated t6he recovery of hormonal
activity in relation to the degree of saturation or
ammonium sulphate that will precitate th maximum
amount of the protein hormone. the result as shown in
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Fig. 27 The flow chart showing the procedure of salt
precipitation in which the inert fraction
obtained by 30% saturation of ammonium sulphate
was removed
Dry Tissue
1 g/100 ml 0.15 M (NTH SOS
Centrifuge 10000 x g 20 minx
cs-1 (400 lU/rig) CPL1
pH 3/0, 5 M H P011
Centrifuge 10000 x g 20 rains
CS-2 (500 Iu/mg) CP-2
30% saturation of (NH4)2S04
Centrifuge 10000 x g 20 mins
CS-3
60% saturation of (NH )2So










Fig. 26. It revealed that the maximum HCG activi ty was
achieved with 50% saturation of ammonium sulphate. The
result also indicated that the protein which was salted
out at 30% saturation of ammonium sulphate; however, no
hormonal activity was detected. Removed of this inert
fraction prior to half saturation of ammonium sulphate
was therefore essential, so that a better crude product
with higher specific activity could be obtained. Fig. 27
showed the procedures and the result of this method. By
this method a crude product with higher specific activity
was obtained (i.e. 1,700 IU/mg). However, this crude
product has certain disadvantage: when it was subjected
to Sephadex G-200, only two major peaks were present and
the activity coincided with the second peak (Fig. 28).
The hormonal active product obtained after Sephadex G-200
chromatography was subjected to DEAF Sephadex A-50 chro-
matography. The final product showed two major components
on disc electrophoresis. As a result of the above findings,
we had to modify the fractionation method as described on
p. 40.
It should be mentioned that the difference between
the dry weight and the protein content as determined by
Folin-Ciocalteu method was probably due to the carbohydrate
moiety of the glycoprotein. The carbohydrate content of
the CP-3D fraction was estimated to be 26% by weight,
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Fig. 28. Chromatography profile of the crude product
obtained from the modified salt precipitation
method on Sephadex G-200 column (2 x 150 cm)













Fig. 29. Elution pattern of the crude product (CP-3D)
on Sephadex G-200 column (2 x 150 cm) at
room temperature in 0.05 N NH4FICO buffer,
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II. Se )hadex G-200 C hroma togs a by
The most active fraction, G-200-2, comprised about
62% of the total activity of the sample before application
to the column. The Sephadex G-200 chromatography had been
performed at room temperature (22°±2°C). It was found the
hormonal active fraction carne out earlier than when it
was performed in the cold (40-l0C) (see Fig. 29). The
result revealed that there may be aggregation of the
hormone molecule at room temperature. Attempts to fractionate
the crude product, CP-3D, by Sephadex G-100 were made; Fig.
30 and Table 14 summarized the results. Two major peaks
resulted after Sephadex G-100 in which the second peak
contained hormonal activity. Since the separation achieved
by Sephadex. G-200 column was better than that of Sephadex
G-100, as shown by their elution patterns, Sephadex G-200
chromatography was therefore employed. The finding dis-
agreed. with that of MQri's (13) who used Sephadex G-100
successfully instead of Sephadex G-200 in the purification






















Fig.30. The elution pattern of the crude product
(CP-3D) on Sephadex G-100 column (2.25 x
114.5 cm)with 0.05 M NH4 HCO3 buffer,pH 8.













III. DEAE Se >Iha dex A-50 Anion -Excha]isre Chromatography
There was a ten-fold. increase in specific activity
of the active product (DE-1) after DEAE Sephadex chromato-
graphy. The result as consistent with that of Hertz (10).
About 90% of the total activity came out at the very
beginning (i.e. DE--1 and DE-2); other fractions comprised
only a few percent' of the total activity and showed yellow
to brown colour. Hence, the appearance of the browwTn pigment
can be used as the i.ndi. c a t or of the inactive fractions,
The purpose of dialysis of the sample vs the equilibrating
buffer before application was to avoid imcomplete equili-
brium between the sample solution and the equilibrating
buffer. It was observed that shrinkage of the column or
irreversible adsorption of the sample on the column resulted
if the sample solution was too concentrated or contained
precipitates.
Canfield et al. (33) used the SE-Sephadex C-50 chro-
matography in the purification of urinary HCG. They found
the hormone was first adsorbed into SE-Sephadex C-50 column
which was equilibrated with 0.05 N NH4Ac at pH 5 and then
eluted by increasing the buffer concentration to 0.1 N
NH4Ac together with 0.5 N NaCl. We investigated the SE-
Sephadex C-50 chromatography in the purification of molar
HCG. However, the result was unsatisfactory.
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Fig. 31. Chromatography profile of the crude product
(CP-3D) on. the SE-Sephadex C-50 column (2.5
x 35 cm) equilibrated with 4 mM NH4Ac buffer
pH 5.5. The adsorbed. fraction was eluted by
increasing the concentration of the buffer
to 0.2 M and 0.4 M. Both adsorbed and unadsorbed
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Our procedure is described below: 70 mg of the crude
product was applied to the SE-Sephadex C-50 co lurnxz (2-5
x 35 cm) equilibrated w:i.th 0.004 r1 NH4 Ac, pH 5-5. A
large amount of protein came out unretarded when eluted
with the equilibrating buffer. The adsorbed fractions
were eluted by increasing the buffer concentration to
0.2 M and finally to 0.4 M. Fig. 31 shows the result of
the elution profile of SE-Sephadex C-50 chromatography.
It was found that both the adsorbed and the unadsorbed
fractions exhibited the hormonal activity. Detailed
studies involved the use of rerun of the adsorbed and
unadsorbed fractions ruled out the possibility of over-
loading the column. The finding-differed from that of
the result of Canfield (33). It was also found that the
specific activity of the eluted product did not increase
significantly (only about 15/ increase), SE-Sephadex
C-50 chromatography was therefore not employed in the
purification of molar HCC.
The effectiveness of CM-Sephadex chromatography on
purification of molar HCG was also conducted. About 40
mg of the protein was applied to CM-Sephadex column
equilibrated with 0.004 M glycine buffer at pH 5.5.
Nearly all the protein carne out of the column unretardeci
when eluted with the equilibrating buffer (Fig. 32).
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Fig. 32. Elution pattern' of the crude product (CP-3D)
on CM Sephadex column equilibrated with lk rnM
glycine buffer pH 5.5. Nearly all the protein
came out of the column unretarded when eluted
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Fig. 33. Disc electrophoresis of fraction G-100--3
on 7/ polyarcylamide gel. The ele ctro-
m obility of the fraction G-100-3 was the
same as the solvent front,
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IV. S Ilex G-100 Chroma togra_p.l y
The purpose of Sephadex G-100 chromatography was
to remove small amounts of contaminated fractions present
in the active fraction after DEAE Sephadex chromatography.
The contaminated fraction (i.e. G-100-1) was removed as
demonstrated by the rechromato ,raphy of G--100-2 fraction
on Sephadex G-100 column under the same condition. (See
result of PART B-III, p. 75). The sample size is extremely
critical in gel chromatography. It was found, if the sample
volume to be added in this column (Vt- 43 ml) was one nil,
the contaminant came out together with the HCG fraction,
giving a single peak on the chromatogram. However,. if
the volume to be applied to column was reduced to 0.4 ml,
the contaminant could be separated from the HCG fraction,
showing two distinct peaks. Hence, overloading of the
sample must be avoided. On rechromatography of the G-100-2
fraction, the fraction G-100-3 appeared consistently on the
chromatogram. The reappearance of the G-100-3 fraction
led us to suspect the final product might be decomposing
during the gel-filtration. The molecular weight of G-100-3
fraction estimated by the position of its elution profile
in Sephadex G-100 was smaller than 1,000. Hence, the
G-100-3. fraction may be carbohydrates or small peptides..
This fraction gave positive result on Folin-Ciocateu's
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reagent and contained large amount of sialic acid. Its
electromobility was the same as the solvent front on
polyacrylamide gel (Fig. 33). Probably the proteolytic
enzyme had cleaved the protein.
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PART B. PIIOP ''RTIES OF HUMAN CUORION]:c GONADOTROPHI1 N
I. Immunoassay
The purpose of using bovine serum albumin (BSA)
in the diluent was firstly to stabilize the HCG molecule
in the solution and secondly to eliminate adsorption of
the HCG molecule to the wall of the glassware. It was
found that the activity increase four folds when 0.1% of
BSA was included in the diluent compared with that of
only 0.9/ saline and 0.01 M Na2HPO4.
Since the potency of the fractions obtained were
calculated by serial dilution until the end point was
reached, the result was only approximate. However, the
result within the upper and the lower limits could be con-
veniently ascertained. Better results would be achieved
if radioimmunoassay (RIA) was employed.
It was found that the crude product having a specific
activity of 1, 000 IU/mg is relatively pure. There was a
slightly increase in specific activity after Sephadex
G-200 chromatography, but there was ten-fold increase in
specific activity after DEAE Sephadex A-50 chromatography.
The marked increase in specific activity indicated the
DEAE Sephadex- column is. an effective ion-exchanger in
HCG purification. In fact, all the workers (10, il, 8,
13, 14, 16) in this field used either DEAE cellulose or
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Fig. 311. Disc electrophoresis of the final product
after dissolving in water at room tempera-
ture and lyophilized twice. Three additional
bands with slower mobility toward the anode
were observed.
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DEAL Sephadex successfully in purification of JICG.
The immunoactivity of tumor HCG is not coincident
with the biological activity. Usually the immunological
activity is lower than the biological activity. Wide
and Hobson (7l) -suggested that. the difference may be
used for differential diagnose of hydatidiform mole.
This difference has been considered (72) as due to
different active site/s responsible for immuno-- or
bioassays.
II. Electrophoretic Pattern on Polyacrylamide Gel
"r1icroheterogeneity" is a common feature of gonado-
trophins due to the instability of the carbohydrate
moiety, probably sialic acid. Hertz (10) found that' the
purified urinary HCG showed three distinct bands on free
boundary electrophoresis. Canfield and Mori (13, 33) also
obtained a diffused, broad band of urinary HCG on disc
electrophoresis.
On close observation of the electrophoretic pattern
of the final product we obtained, the HCG band was present
as a distinct one. Hoy, ever., if the molar HCG solution was
left at room temperature and lyophilized twice, the final
product 'showed three additional bands with slower mobility
toward the anode on disc electrophoresis (Fig. 34). Whether
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these three additional bands correlated with the three
bands of Hertz's needs further clarification. The
dissociation of one or two of the sialic acid. molecules
will increase the positive charge of the protein, and
probably reduced the mobility of the protein toward the
anode.
From Fig. 14, it was found the HCG band appeared
in most fractions. The presence of the HCG band in the
crude extract can be used as a screening test during
the purification. The location of the HCG band can be
obtained by assaying the gel after electrophoresis,
The electrophoretic pattern of the crude preparation,
CP-3D, reveals only three bands, whereas in the DEAE
Sephad.ex A-50 treated fraction, i.e. DE-3, DE-4, DE-5, DE-6
and DE-7, more bands appeared. Usually, five to six bands
were present. This may be attributed to two factors:
a. Artifacts;
b. Concentration of the proteins appeared as the
minor bands has increased as a result of the
purification.
It should be mentioned that the hormonal activity
is present in DE-1 and DE-2 fractions which are subjected
to further purification..
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III. Electr. ophoret:Lc Pattern On Starch Gel
The final product showed a single band on starch gel
electrophoresis. The mobility of the final product re-
lative to BSA was 0.51. It had been reported that hetero-
geneity of IICC was observed on starch gel electrophoresis
(12). However, the present method of fractionation has
overcome this difficulty. Here our final product yielded
only one distinct band. The pure urinary 1iCG purified by
Hell et al. showed three distinct bands with Rf values of
0.76 0.71 o.68, on starch gel electrophoresis. All of
them had hormonal activity. He interpreted his result as
the occurrence of "isohormones" of HCG. However, this
heterogeneity on starch gel was not observed in molar HCC.
It was found there were fewer bands on starch gel
electrophoresis compared with that by disc electrophoresis.
Only one or two major bands were observed whereas other
minor bands showed a smear on starch gel. The result
revealed the resolving power of starch gel electrophoresis
is less effective than that of disc electrophoresis.
A preliminary study of assay on gel sections after
electrophoresis had been done. The result exhibited
that the HCG band was immunoactive. It may be mentioned
that further investigation by immunoelectr_ ophoresis on
agar gel may be more informative.
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IV. Molecular Weight Determination (M.W) by Sephadex G-200
It had been indicated that glycoprotein had a more
expanded structure than those of globular protein due
to greater hydration property of carbohydrate chains (73).
The molecular weight is usually found higher when compared
with the result by ultracentr. ifuc;ation method. The value
of molar HCG is higher than the others (see Literature
Review, PART C -I, p,26). This is because of the larger
size of molar HCG as discussed by Ashitaka et al. (16)
and also the higher carbohydrate content of molar HCG
molecule.
Ashitaka et al.. (ibid) stated that HCG molecule of
tumor origin was larger than that from normal pregnancy.
The reason was based on the following facts:
a. On Sephadex gel filtration, HCG from hydatidiform
mole and chorionic tumor is eluted before that of
normal trophoblastic tissue.
b. HCG from tumor origin contains a much larger amount
of sugar component than I-ICG from normal pregnancy
does,
c. The phenomenon that longer circulation time of
HCG in serum of patients of hydatidiform mole
may be due to the. larger size of molar HCG which
can not be released with ease from the trophoblastic
cell.
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d. IICG in tumor may be a polymer of "smaller sized
IICG1! similar to the finding of molar thyrotropin
(74). Hershman et al. (74) found that the thyro-
tropin extracted from hyd.atidiform mole showed
larger in molecular size by gel filtration as
compared with that of human chorionic thyrotropin.
They suspected that the human chorionic thyrotropin
was a precursor subunit of molar thyrotropin.
Gel filtration method only gives the apparent size
(i.e. Stokes radius) of a macromolecule instead of its
molecular weight. This was discussed in detail by Siegel
et al.. (75). As pointed out by Siegel et al., the true
molecular weight can only be obtained if both Stokes radius,
determined by gel filtration, and sedimentation coefficient,
determined by ultracentrifugation, were available. The
molecular weight of macromolecules can be obtained by the
following equation:
M= 67(u Nas/(l- -V-








It is seen that the value of molecular weight is dependent
upon the values of three parameters---Stokes radius, sedi-
mentation coefficient and partial specific volume. Since
the partial specific volume can he estimated and its value
varies over quite a narrow range for most proteins, only
Stokes radius and sedimentation coefficient are truly
independent variables in the determination of the molecular
weight of proteins. The estimation of molecular weight by
either sedimentation technique or by gel filtration method
depends on only one single parameter, assuming that the
other parameters will change linearly with the experimental
parameter. However, combination of the two experimental
methods allow a much more reliable estimation of molecular
weight, since- the value of partial specific volume was
roughly a constant for most proteins. It was also noted
that when values of the Stokes radius, sedimentation coeffi-
cient and partial specific volume are knovvn, the frictional
Threfore, the valuable information concerning the shapes
of the protein. can be obtained.
The sodium dodecyl sulphate (SDS) polyacrylaniide gel-













weight was first demonstrated by Weber and Osborn (76).
The result of this method in the determination-n. of molecular
weight is comparable with the result of ultracentrifug-at:i.on
method. This method also has several advantages that only
a small sample size is needed, convenient to perform and
especially good for subunit molecular weight determination.
Further investigation by this method is worthwhile.
V. Isoelectric Point (pI) Determination- Isoelectro-
focusing
The isoelectric point (pI) is an important parameter
of proteins. Values obtained by the usual techniques, such
as free boundary electrophoresis, are strongly influenced
by the type of buffer employed as well as its ionic strength
(77). A recent technique using ampholine electrofocusing
minimizes the above hindrance factors in pI determinations.
When Ampholine (a group of polyamino-polycarboxylic acids
with various PI values) is subjected to the influence of-
an electric field, it moves and forms a pH gradient. If
the protein is mixed with the ampholine, the sample protein
also moves under the electric field until it has reached
the position where the pH value of the ampholine zone equal
to its pI value. Hence, an accurate pI value of the protein
can be obtained. The pI of molar HCG was determined by
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Table 15 Isoelectric point of HCG from various sources
Sources PI
Urinary HCG from normal pregnant women 2.95Hertz
(1960) Urinary HCG from patients of trophoblastic tumor
308-400
Urinary HCG from normal pregnant women
3Hammond






this method and found to be 4.2±0.1.
Table 15 displays the results of pI values of urinary
HCG obtained by other workers and compared with our value
of molar HCG. As seer from the Table 15, the pI values
of molar HCG and. the urinary HCG isolated from patients
of trophoblastic diseases, are higher than those of normal
urinary HCG in pregnant subjects. Since the pI value of
desialic HCG was even higher, i.e. 6 (23, 24), it was
suspected the high value of pI of the abnormal HCG was due
to less NANA present. This will be verified as soon as
more data on NANA content of the abnormal HCG are available,
which we shall investigate in the near future.
An attempt to use starch gel electrophoresis for
determining the pI value of molar HCG was made. The
detailed procedure is described by Smithies (63). Sodium
acetate buffer with ionic strength 0.1 was used as gel
buffer and bridge buffer. The pH values of the gel media
ranged from 4.8 to 5.3. The electrophoresis was performed
under a constant potential of 5 volt/cm. across the tray
for 25 hours at room temperature (22°±2°C). Fig. 35 shows
the mobility of the protein at different pH media under
the electric field applied to the starch gel. The protein
moved-to the anode above pI3 5.3 and moved to the cathode
below pH 4.8. No mobility was observed at pH 5.1. The
result indicated the pI of molar HCG was around pH 5.1,
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Fig. 35. Diagram of starch gel electrophoresis
of the final product at different pH
media. The protein did not move at pH









Fig. 36. Isoelectrofocusing of 20 mg of G-200-2
fraction on 4% ampholine pH 3-10. The
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which is higher than the value determined by isoelectro-
focusing technique, i.e. 4.2. As pointed out earlier,
the starch gel electrophoresis is influenced by the type
of the buffer employed, ionic strength, the pore size of
the gel medium and by the electro-osmotic effect, and hence
resulting in different pI values o
Since microheterogeneity had been found in most HCG
preparations, it was hoped that isoelectrofocusing technique
might separate the heterogeneous bands of HCG; hence a
homogeneous product of HCG could be obtained. Rathnam
(78) obtained three highly active and homogeneous luteinizing
hormones (LH) using the isoelectrofocusing technique. The
same method was followed*-, About 20 mg of fraction G-200-2
was applied to the isoelectrofocusing column containing
4% ampholine with pH values ranging from 3 to 10. After
the run for three days.-at 4°C, the content in the column
was eluted (Fig. 36). The active fraction was re-run for
another three days and the content in the column was eluted
similarly. Fig. 37 shows the final result explicited as
a plot of optical density (O.D.) at 280 nni. and pH values
against tube numbers. An active fraction was well separated,
having a pI value of 4.3 as determined by the apex of the
peak and, the pH curve. However, the final product obtained
was almost inactive. The recovery of activity was less
Fig. 37. Isoelectrofocusing of the hormonal active
fraction from the first isoelectrof_ocusin.g.

















than 10%. The loss of activity, we believe, is probably
due to denaturation of protein during the long experiment.
VI. N-terminal Determination- Dansylation Method
It was first found that the intensity of DNS-Ser
and DNS-Ala was rather weak on polyamide sheet under
UV light, even adequate amount was applied. The reason
was that the DNS-Ser and DNS-Ala decomposed on acid
hydrolysis to give DNS-OH (66). The recovery of DNS-Ser
and DNS-Ala after acid hydrolysis (i.e. 6 N HC1 at 105°C
for 16 hours) was only 650/o and 93% respectively. Hence
the intensity under UV was somewhat reduced.
There are two N-terminal amino acids detected. This
indicates the molar HCG is composed of two polypeptide
chains, which is consistent with the findings by other
workers (15, 33). It is therefore worthwhile to separate
the molar.I-ICG into its subunits in order to ascertain
which N-terminal amino acid corresponds to which subunit.
Canfield et al. (69) investigated the N-terminal amino
acid of HCG and its subunits by Edman's phenylisothiocyanate
(PITC) method. He found that the N-terminal amino acid of
native HCG were Ala, Ser and Val. The N-terminal amino
acids of alpha and beta subunits were Ala, Val and Ser., Ala
respectively. 'Bahl (8) in 1969 found. difficulty in
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determining the N--terinina1 of HCG using either leucino
amino peptidase or by Sanger's procedure. But he used
the dansylation method successfully in the squence work
of HCG (15). The N-terminal amino acid of urinary IHCG
was Ala and Ser.' The result was in excellent agreement
with ours of the molar HCG.
The main advantage of dansylation method is its
ease and rapidity with which end group can be- determined
on very small amount of material. One nmole of dansyl
derivative of amino acid can be detected under UV light.
However, there were limitations of this method, such as
the N-terminal tyrosine can not be identified after acid
hydrolysis and the formation of dansyl dipeptides with
the N-terminal valine or isoleucine which gives rise to
interference.
VII. Sialic Acid Determination
It was reported that the sialic acid in gonadotro®
phins played an important role in the hormonal activity (43)
Kunii (44) found that the loss of biological activity of
HCG up to 90% resulted when HCG was incubated with neura--
minidase for one hour. Van Hell et al. (12) reported that
sialic acid content of HCG was proportional to its potency
and in 1971, they (80) studied the relationship between
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the progressive de.sialylation of IICG and the iintiiuuurto-
logical as well as biological activity. They found the
biological activity was affected by the sialic acid
content while the immunological activity was unchange.
Similar result for LH was obtained (81). Molar HCG
contains 5.45/ of sialic acid which was low as compared
with the result of Ashitaka et al. (16) and urinary HCG
(8, 10, 11, 12, 13, 14). However, a correlation betifeen
the sialic acid content and the activity of the hormone
was obtained. Since HCG contains sialic acid, the increase
in sialic acid content during purification can be taken
as a measure of the purity of this protein hormone.
VIII. Amino Acid Composition Determination
There was difference between the amino acid com-
position of molar HCG and the urinary HCG. The amount
of amino acid residue of Lys, Asp, Gly, Ala is higher
in molar HCG while the Thr, Ser, Pro and i cys is lower
as compared with the urinary HCG (see Table 2 and 12).
Since the molecular weight and carbohydrate content are
different for these two molecule, it may be unreasonable
to believe their amino acid composition is identical.
As Canfield (33) pointed out, there may be degradation
of HCG molecule by certain pl•oteolytic enzyme present
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in the urine extract during storage before purification.
An advantage of studying the HCG, molecule in molar tissue
would be: a genuine native hormone present within the
intact cells.
We intend to further investigate the amino acid
composition of molar HCG as soon as an amino acid analyser
is available. By comparing the composition of molar HCG
and urinary HCG, we hope a better understanding of.th e
HCG molecule can be achieved.
IX. Heat Stability
It was reported that the activity of LIi deteriorates
under moist condition (79). Papkoff believed that the
destruction of activity was due to the presence of
proteolytic enzyme in the crude extract. Hence, he
destroyed the proteolytic enzyme by means of heating
during the purification process.
However, Mori (13) conducted a similar experiment
to test the heat stability of urinary HCG at 6o°C for
15 rains. The biological activity, as assayed by ovarian
hyperemia method, was much reduced whereas the i.mmuno-.
activity retained to as much as 93%. Our result on
molar HCG confirms that of Mori. It would be interesting
to investigate such difference between LH and HCG.
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PART C. GENTERAL DISCUSSION
The fractionation of molar HCG as presented above
includes four major steps:
l. Salt precipitation;
2. Sephadex G-200 chromatography;
3. DEAE Sephadex A-50 chromatography; and
4. Sephadex G-100 chromatography.
The salt precipitation is effective and gives a good
crude product, as evidenced by its activity and pure,
white colour. This, we wish to emphasize, has made
further purification much simpler.
Sephadex G-200 chromatography separates the crude
product into three fractions and the fraction G-200-1,
which is hormonal inactive, can not be removed by DEAE
Sephadex, since this fraction conies out together with
the HCG fraction. The main purpose of DEAE Sephadex
chromatography is to isolate HCG from other components
so that the specific activity is increased considerably.
Sephadex G-100 chromatography serves to clean the minor
contaminants still present after the treatment with DEAE
Sephadex.
The total recovery of activity for every individual
step, i.e. for salt precipitation, Sephadex G-200, DEAE
Sephadex and Sephadex G-100 chromatography are 67%, 95%
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75% and 98% respectively. The loss in total activity
takes place mainly during the salt precipitation step.
The recovery of total initial activity for the most
active fractions after the above four steps i.e. CP-3D,
G-200-2, 1)E-1 and G--100-2 were: 50%, 32.5%, 20% and 19.7%
respectively. The, recovery yield in terms of hormonal
activities will be discussed later. The yield of the
final product is 0.27% on the dry basis, which is remark-
ably high. As compared with the result of Ashitaka et al.
(16) whose yield was only 0.017%, the present method.
obtained a 16-fold increase, which is markedly significant.
The homogeneity of the final product was examined
by the following criteria:
1. A single band on polyacrylamide gel electrophoresis
at pH 9 and pH 5.
2. A single band on starch gel electrophoresis at
pH 8.6
3. A symmetrical peak on, gel filtration of Sephadex
G-100.
4. N-terminal determination indicating only two
N-terminal amino acids were obtained.
Heterogeneity is a common feature for HCG preparation
and many workers (10, 11, 12, 13) suspect that IHCG exists
in a complex form rather than a single entity. However,
our results. could not confirm this. The molar HCG is
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homogeneous in charge as demonstrated by its electro-
phoretic pattern and by its size as shown in the elution
pattern of. Sephadex G--100.
The molecular weight of the molar HCG is 6.3 x 104
as determined by gel filtration which-is somewhat higher
than the urinary HCG (around 5. 9 x 104} (8). The iso-
electric point of molar HCG as determined by isoelectro-
focusing technique is 4.2±0.1 which is also higher than
that of the urinary HCG (10, 23, 24). But our finding
is comparable with the result of the pI of abnormal
urinary HCG, the pI of which being 3.8-4.0 and 4.5.
The sialic acid content of molar HCG is 5.45% by
weight. This value is lower than that of urinary HCG
and may be attributed to the instrinsic property of molar
HCG or to the dissociation of the sialic acid during
purification which was demonstrated by the rechroniato-
graphy of the final product on Sephadex G-100 (see
Discussion PART A-IV, p. 106). However, a correlation
between activity to the sialic acid content is observed.
The N-terminal amino acids of molar HCG are Ala and
Ser which are essentially the same as urinary IICG. This
result strongly suggests the molar HCG molecule is com-
posed of two polypeptide chains.
The activity of the final product was 2.1 x 104
IU/mg as determined by immunoassay. The result is higher
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than that of urinary I-ICG but lower than the -result of
Ashitaka et al. (16) who obtained a product with a
specific activity of 2.6 x 10 if IU/mg.
The present method of fractionation of HCG from
molar tissue is comparatively simple, particularly when
compared with the one designed by Ashitaka et al. (16).
Their method employs percolation, Sephadex G-50, CM-
cellulose, Sephadex G-100, DEAE cellulose and DEAE
Sephadex chromatography. Since HCG. is an unstable
glycoprotein, the more steps are involved in purification
the more chance for the protein to be degraded. In
addition, the higher yield and recovery of activity
reveal that the present method is a procedure of choice
to fractionate HCG from molar tissue.
Urinary HCG is unstable. The instability of the
hormone renders its purification more difficult. Molar
HCG is also unstable, which is demonstrated by the lose
of its activity and by its change in physicochemical
properties, such as the additional bands appeared in
polyacrylamide gel electrophoresis and the consistent
presence of small fragments during repeated Sephadex
G-100 chromatography of the final product (see Discussion
of PART A-IV, p. 106)- Hence, both urinary and molar HCG
must be fractionated with care.
The above phenomenon of instability may be attributed
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to instrinsic c ar ges, including its conformational
change, dissociation of the native protein. It may also
be due to other substances present in the environment or
contaminants which attack or affect the native hormone,
such as proteolytic enzymes and/or inactivators. In order
to avoid or reduce the chance of denaturation, fractionation
of molar HCG is therefore conducted strictly in the cold
(i.e. at 4C) and is processed as quickly as possible.
It is found, if the procedure is operated at room temperature,
in addition to great lost of activity, there is aggregation
of the hormone as demonstrated by the gel filtration of
Sephadex G-200 chromatography (see Discussion. PART A-II,
p. 99). The loss of activity is also taken place after long
storage even under refrigeration. The possible reason is:
sample contains moisture which facilitates digestion of the
protein by proteolytic enzymes. It is observed that the
total activity is usually found low in the highly bloody
molar tissue. We consider that total activity being low
may be attributed to the .proteolytic enzymes present in
blood such as cathepsin-like proteinase (82) that readily
digest the protein in acidic medium. The phenomenon, may
also account for the great loss of activity in salt preci-
pitation since this step. is performed in acid medium.
In general, glycoproteins are less stable because of
its carbohydrate moiety. Molar HHCG comprises of about 50%
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carbohydrates by weight (111, 16). The dissociatio)-) of
certain carbohydrates caused by enzymes such as neura-
minidase, glycosidases present in the medium should not
be ruled out. This will inevitably causes conformational
changes and alterations of electrical charges of the protein.
In turn, this would affect the active site of IHCC. Denatu-
ration may also easily creep in during dialysis and lyophi--
lization. We have encounted in many occasions that. the
lyophilized product could not be completely redissolved.
It should be emphasized that molar HCG is less unstable
in a protein-rich environment: a good example being the
enhance effect when BSA is provided for in the-diluent for
immunoassay. Molar HCG may probably need another protein
with which it can adhere to. Such requirement is known to
apply to carbohydrate moiety of HCG which needs another
protein in order to establish a proper conformation essential
for immunoassay. However, we must not abandon the possibility
that in a protein rich environment there is less chance for
HCG to be attached by proteolytic enzymes.
The total activity in hydatidiform mole varies greatly
from specimens to specimens. This may be due to two reasons:
1. the instrinsic total activity of the mole depends
on the time when the hydatidiform mole tissue is
removed;
2. chemical changes takes place before the specimen
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reaches our laboratory; prolonged washing to
remove contaminated blood 'pigments may also
reduce the activity.
Bioassay of the final product has not yet been
determined because of the present facilities available.
However, the biological activity of fraction G-200-2 is
measured using Ovarian Ascorbic Acid Depletion (OAAD) for
LH activity and, also, Augmentation assay of Steelman and
Pohley for FSH activity. These assays were performed
through the kind arrangement made by Professor C. H. Li and
Professor J.* Porath. The biological activity of fraction
G-200-2 was 0.65-1.7 NH-LH-S 14 units for LH activity and
contained less than 20 IU of FSH activity. Immunochemical
method provides a valuable tool in the characterization of
proteins because of its sensitivity, specificity, less time-
comsuming; in addition, it is simple and less expensive. We
have therefore utilized the immunoassay as the screening
test throughout the present purification procedure of molar
HCG.
The possibility that the placental HCG contained follicle-
stimulating activity was first suggested by Lyon et al. (83).
Ashitaka et al. (114, 16) obtained the two distinct substances
(i.e. HCG-LH and HCG--FSH) from urine of patients suffering
from trophoblastic disease as well as from hydatidiforin
mole tissue. But it remains a question whether:
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1. the follicle tirniula tin` substances was a consta•--
minaYn t of pituitary origin; or
2. an intrinsic property of IICG; or.
3. an independent entity presented in the molar tissue.
This we intend to clarify in future experiri-ientso We shall
also investigate the follicle-stimulating substance present
in the molar tissue as soon as the bioassay facilities are
available in our laboratory.
Our next goal is to. separate molar IHCG into subunits
so that their physicochemical- properties such as. N-- and
Ca-terminal amino acids, carbohydrate content, amino acid
composition, biological and immunological activity can be
elucidated. Recent findings (84) indicates that all gona-
dotrophins are composed of two subunits. The alpha subunit
shares a common immz .nological property. They have similar
amino acid compositions and molecular sizes while the beta
subunit is hormonal specific. In fact, the alpha subunit
of gonadotrophins were interchangeable among gonado trophins
(i.e. FSH, LII, IICG) while the beta subunit could not, as
demonstrated by Sexena (85) and Reichert (35), Reichert
(1970) (70) even constructed the hybrid molecule of LIB
from sub#nits of bovine and human LIIe In 1972, Reichert
(35) found that then the mixture of alpha and beta subunits
of FSH were incubated with the alpha subunit of HCG, the
resulting product showed 81% recovery of FSII activity and
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only a small amount of HCG activity. However, when the
mixture of alpha and beta subunits of I SI-I were incubated
with beta subunit of HCG, the resulting product showed
major HCG activity and only 12% recovery of FSI-I activity
(see Table 16)e Since both beta subunits of FSH and IICG
were present in the incubation mixture, the enhanced HCG
activity indicated the beta sul:)unit of HCG. had a higher
affinitive of alpha subunit irrespective to its origin.
It will be interesting to conduct similar work of
constructing hybride molecules by the combination of sub-
units of molar HCG, urinary HCG, as well as LH and FSH.
In this way their structural relationship to their activity,
both the biological and immunological, can be elucidated.
It is also worthwhile to study the kinetic mechanism
of the combination of gonadotrophin subunits. How they are
combined reversibly? The reversible combination may even
come from different origins, i.g. one from pituitary and
the other from placenta. Is them any relation to the
evolutionary aspects of mammals? A better understanding
will be obtained when their amino acid sequencies as well
as their carbohydrate sequencies are known.
In this -chapter we have discussed problems in frac-
tionation of molar HCG together with the properties of the
final product. Future investigations on molar I-ICG have been
suggested in the light. of our present work.
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Table 16
+ HCG() FSH (3470 IU/mg) 81%
HCG (89 IU/mg)
separation FSH (1063 IU/mg) 25%FSH (native)separtion FSH(+) recombination
(4279 IU/mg) 100% (198 IU/mg) HCG (43 IU/mg)




C 0 N C L U S z 0 N
Our present studies of the fractionation of molar
HHHCG have made the procedure simple: there are only four
steps involved, namely, salt precipitation., Sephaa.dex G-
200, DEAE Sephadex: A-50 and Sephadex G-100 chromatography.
We find the present, salt precipitation is effective and the
treatment by the above three chromatographic columns is
easy to handle. The whole fractionation, from fresh molar
tissue to the final product, takes only 10 days. The reco-
very yields calculated on the following are:
1. Dry weight basis-, 0.27"1
2. Hormonal activity basis: 19.7%.
The above values are remarkably high, particularly
when compared with the method by Ashitaka et al. (16).
The final product shows homogeneity as determined by
polyacrylamide and starch gel electrophoresis; only one
single band is detected in both cases. N--terminal analysis
reveals the presence of Ala and Ser, which are consistent
with the finding of urinary IICG, attributed to alpha and
beta chains of this protein hormone. No other amino acids
are observed in the N-terminal analysis, indicating the
absence of "micro-heterogeneity" as considered by Canfield
(33). The elution pattern of the final product in Sephadex
G-100 displays a syrnrnetical profile, which is an evidence
of the homogeneity of the size of this protein.
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The present investigation suggests there are certain
quantitative differences between molar 1-ICG and urinary 11CG.
of normal pregnancy:
1. The molecular weight of molar. HCG as determined
by Sephadex G-200 is 6-3 x 104 whereas the urinary
HCG as determined by other workers (8, 13) using
the same technique ranges between 3.7 x 104 and
5.9 x 104.
2. The isoelectric point also differs. For molar I-1CG,-
pI is 4.2 whereas for urinary HCG, 3.0 (10, 23, 24).
Hence, the charge carried by the two proteins is
different.
Further studies on molar HCG are suggested, which, we
believe, may help better understanding of this placental
disorder. These are summarised as follows:
1. Separation of molar HCG into its subunits is of
importance, following which the amino acid sequence
may be ascertained. As a result, the primary
structure of. molar HCG and urinary HCG of normal
pregnancy can be studied on a comparative basis.
In addition, kinetic studies of the recombination
of subunits from different sources should also be
investigated (see p. 134).
2. By. means of perturbation and chemical modification
techniques., we hope to study the conformational
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aspects of molar IICC Q Thus, the active r:Lte/s
of molar IJCG may also he elucidatcocl.
30 When facilities, for breeding experimental animals
are available, studies by means of ir;mrnuno-.diffusion
and imniuno-electrophoresis will be extremely useful
in correlating the biological function in relation
to its structure. Thus, better understanding of
this protein hormone can be made.
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